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ABSTRACT 
Introduction: 
The complications associated with diabetes usually occur over a long period of time and 
are mainly influenced by poor glycaemic control. Diabetic complications impact on the 
individual, the healthcare delivery system, and also have high cost implications. A number 
of studies have shown the management of diabetes to be sub-optimal in primary health 
care settings. Barriers that impair a patients’ ability to achieve good glycaemic control can 
be looked at from a patient, health facility and health professional perspectives. Good 
glycaemic control will not only benefit the individual patient but will also have a positive 
financial impact on South Africa’s already overstretched healthcare budget. 
 
Methods: 
In this cross sectional analytical study set in three Community Health Centres (CHCs) in 
the Johannesburg Metropolitan Health District, 418 diabetic patients were selected. An 
HbA1c test was conducted for every patient and was used to classify patients into a well 
controlled glycaemic group (HbA1c < 7%) or a poorly controlled group (HbA1c ≥ 7%).  
Differences between the two groups in terms of their risk factors for poor glycaemic control 
were investigated. Patient related risk factors studied included, basic demographic, 
treatment related, clinical, behavioural and lifestyle characteristics. Healthcare 
professionals and facility managers were interviewed and patient records were reviewed to 
describe health system challenges to providing optimal care. Univariate and multivariate 
logistic regression models were used to determine patient related factors influencing 
glycaemic control. 
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Results: 
Of 394 patients with a measurable outcome (HbA1c), only 62 (15.7%) had well controlled 
diabetes. The mean HbA1c was similar across the three CHCs studied (p=0.464). Good 
glycaemic control was significantly associated with unemployment, shorter duration since 
diabetes diagnosis, treatment with oral medication alone and normal LDL-cholesterol 
levels (p<0.05). On multivariate analysis significant predictors of good glycaemic control 
were found to be a shorter duration since diabetes diagnosis, treatment with oral 
medication alone, being male, and those who were unemployed. 
Numerous challenges to providing optimal diabetes care were reported by health 
professionals including high patient to staff ratios, lack of working equipment as well as a 
need to improve diabetes management skills. Record review revealed that only a limited 
number of patients (16%) had ever had HbA1c testing.  
 
Conclusions: 
The majority (84.2%) of patients attending the selected facilities for diabetes care had poor 
glycaemic control. Management of diabetes in these CHCs is suboptimal. Patients with a 
shorter duration of diabetes, those who were male, Black African, unemployed and treated 
with oral medication alone were more likely to have good glycaemic control. Although the 
study concludes that patient related factors are at the forefront in terms of factors 
influencing glycaemic control, improved strategies in all spheres can only improve diabetes 
management at the CHCs.  
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CHAPTER ONE  
1.0 INTRODUCTION 
The purpose of this study was to describe and determine factors that influence 
glycaemic control in diabetic patients attending community health centres in the 
Johannesburg district. This chapter gives an introduction and background to the 
topic, as well as a review of relevant literature.   
 
1.1 Background 
Diabetes is a complex chronic disease which accounted for 5% of all deaths globally 
in the year 2000.1 In 2006, The World Health Organisation (WHO) estimated that 
more than 180 million people worldwide had diabetes and this number was predicted 
to double by the year 2030.2 These predictions of a global increase in the burden of 
diabetes places the onus on world healthcare leaders to ensure that they implement 
effective management strategies to address this burden. 
 
Diabetes complications such as stroke, diabetic neuropathy, amputations, coronary 
artery and peripheral vascular disease, renal failure and blindness have resulted in 
an increase in disability and have frequently been the cause of death in people with 
diabetes.3 Diabetes is known to be the most common cause of non-traumatic 
amputations and is a leading cause of blindness worldwide.1 Diabetes can also 
cause end stage renal disease, which often requires dialysis or even 
transplantation.1 In comparison to the general population, persons with type 1 
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diabetes and type 2 diabetes have a 4 - 7 and 2 – 3 times higher death rates 
respectively.4 The WHO has estimated that 80% of all diabetes related deaths occur 
in low and middle income countries.2 The burden of complications and premature 
mortality associated with diabetes constitutes a major public health problem for most 
countries and creates an enormous financial burden on the healthcare system. 
 
In Africa, it is predicted that the prevalence of type 2 diabetes will increase by 80% 
by 2025, as opposed to 55% globally.3 In South Africa the prevalence rates of 
diabetes, already being between 4% - 6% of adults, are higher than the African 
average, especially in urban areas.5 In 2000 it was estimated that 2 to 3 million 
people in South Africa were affected with diabetes mellitus, of which more than 1 
million were undiagnosed.6 The 2000 Burden of Disease study estimated the 
prevalence of diabetes among South Africans over 30 years of age to be 5.5% in the 
year 2000.1 The revised estimates from the Burden of Disease 2000 report, 
highlighted that diabetes contributed to 3.5% of all female deaths and 1.8% of male 
deaths.7 In 2004, diabetes was the sixth most common cause of death in South 
Africa and seventh in Gauteng.8 The expanding burden of this disease is shown by a 
rise in morbidity; including a high prevalence of end-stage renal diseases, and a 
rapid increase in diabetes related mortality among South Africans.9   
 
Studies show that risk factors associated with the development and prevalence of 
diabetes include age, sex, family history, high body mass index, sedentary lifestyles, 
unhealthy diets, ethnicity, race as well as urbanisation.2,4 The burden of diabetes  
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however is mainly related to its complications, both microvascular and 
macrovascular. The risk factors for the development and progression of diabetic 
complications include hyperglycaemia, the impact of hypertension, high lipids, age, 
sex and genes.2,4,10-12  
 
Evidence shows that good glycaemic control, as measured by glycated haemoglobin 
(HbA1c), reduces the risk of developing diabetic complications.1,13-17  The United 
Kingdom Prospective Diabetes Study (UKPDS) showed that in type 2 diabetes,   
each 1% reduction in mean HbA1c was associated with reductions in risk of 21% for 
deaths related to diabetes ,14% for myocardial infarction and 37% for microvascular 
complications .18 
 
Diabetes and its complications, not only cause human suffering but also have a 
significant impact on the economy of a country and its healthcare system.2 It has 
been estimated that the life time medical costs for patients with diabetes are more 
than double those without the disease.19 In addition the occurrence of diabetes co-
morbidities in type 2 diabetics are reported to be associated with an increase in 
average annual medical costs.20 Strategies aimed at preventing the onset of 
diabetes complications are likely to reduce medical costs in the long term, whilst 
improving patients’ health. In developed countries most people with diabetes are 
above the age of retirement, whereas in developing countries those most frequently 
affected are aged between 35 and 64, which is their most economically productive 
years.24 
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Beaglehole and Yach21 indicated in 2003 that the improvement in terms of non-
communicable disease prevention and control was occurring very slowly. The quality 
of care of patients with diabetes varies throughout the world.25 They highlighted that 
in order to make progress in prevention and control efforts numerous bodies 
(including governments, relevant international agencies, non-governmental 
agencies, and the general population) would all need to acknowledge that public 
health efforts must refocus and include non-communicable diseases and their risk 
factors as a priority target for intervention.33 
 
In Africa, health systems are geared mainly for the treatment of acute conditions 
rather than chronic conditions and Tavis et al22 and Whiting et al23 have highlighted 
some failings of the health systems in Africa with regards to diabetes care. These 
challenges include: short consultation times due to heavy patient volume, leaving 
little or no time for quality care or patient education; inequitable access to services; 
poor patient compliance to medication as well as appointment keeping; lack of 
physical infrastructure and equipment; deficiencies in human resources – need for 
more training, better utilisation of existing resources, and better supervision; 
inadequate drug supplies; poor service management; complications are not 
monitored or evaluated in a systematic manner; poor control of blood glucose; 
inadequate referral systems; lack of communication; poor organisation of services 
and poor record keeping.22-23  Also less developed countries have less money for 
diabetes care therefore the care offered is likely to be inadequate.24  
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Africa is also experiencing one of the most rapid demographic transitions, a 
phenomenon that can be linked to the global trends of an increased prevalence of 
diabetes in African populations. The urbanisation of South Africa’s Black population 
is rapidly increasing with an estimated 56% of the country’s population now living in 
urban areas.28 This rapid urbanisation has resulted in changes in the epidemiology of 
diseases in South Africa, including diabetes. Urbanisation, known to be a major risk 
factor for chronic disease development is associated with dietary changes which are 
considered more westernised. This includes the higher intake of animal protein fats 
and sugars.29 Lifestyle changes associated with urbanisation include cigarette 
smoking, alcohol consumption and lower physical activity levels. All these factors 
increase the risk of developing chronic diseases, including diabetes and some may 
even contribute to the development of chronic disease complications.  
 
Most chronic disease conditions are managed at the primary level of care. In South 
Africa chronic disease management is offered at both private and public primary 
health care facilities.  
 
1.2 Statement of the Problem 
Studies conducted in South Africa, mainly in the Western Cape Province; show that 
many diabetic patients in the public sector remain poorly controlled.9,15,26,30-35 
Diabetes management has been shown to be suboptimal with a  high prevalence of 
unrecorded diabetic complications.9,12,15,30-32,36-37  
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The quality of diabetes patient care and glycaemic control can be influenced by 
patient factors, health professional factors or organisational factors17 and numerous 
studies worldwide have already highlighted the various factors that hinder optimal 
management of this disease.12,14-17,25,30,38 To improve quality of care, a better 
understanding of the various factors that are possibly associated with good 
glycaemic control, is essential.  
 
Beattie et al26 highlighted some of the obstacles to achieving good glycaemic control, 
in his evaluation of diabetes care at primary level facilities in SA from the 1990’s, 
which included costs to patients, transport difficulties, lack of health education and 
shortcomings in clinical expertise.26 
 
In 2004, The National Department of Health in South Africa issued guidelines for the 
management of diabetes at the primary level.27 On the basis of evidence, these 
guidelines in place at the time of this study, aimed for optimal control of glycaemia as 
well as modifying risk factors for future diabetic complications. However, despite 
increasing recommendations regarding diabetes management and glycaemic 
control, many individuals with diabetes are not managed according to these 
guidelines.2,13,15,39-41  
 
The complications associated with diabetes are patient specific, dependent on time 
of diagnosis as well as level of glycaemic control, and may occur over a long period 
of time. The need for the comprehensive management of diabetes is critical. 
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Diabetes management in South Africa has to be targeted at prevention of this 
disease, as well as early treatment in order to prevent complications.27 Knowledge of 
factors that influence quality of care in diabetes in the Johannesburg area may 
therefore be helpful in implementing quality improvement programmes. 
 
1.3 Justification for the study 
Although studies have been conducted in South Africa on the management of 
diabetes, as well as on factors influencing glycaemic control, little has been done in 
Gauteng. Gauteng is the smallest province in surface area; it is regarded as the 
country’s economic heartland and is the most densely populated province in South 
Africa. Despite being mainly an urban province, there is also a significant peri-urban 
population and high proportion of migrant workers.  
 
This study will attempt to describe the patient, health care professional as well as 
health facility related factors that influence glycaemic control in the Johannesburg 
Metropolitan Health District. The findings of this study may enable the Gauteng 
Department of Health (GDoH) to develop and implement targeted interventions that 
could contribute to decreasing the burden of diabetes.   
 
1.4 Literature Review 
Good glycaemic control has become an important goal of diabetes care. Studies 
have shown that intensive diabetes management with good glycaemic control 
reduces microvascular as well as macrovascular complications.18,42 Glycaemic 
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control is a measure / indication of whether blood glucose is maintained within a 
normal range in diabetic patients. Glycaemia refers to the presence of glucose in the 
blood. This level of blood glucose can fluctuate constantly.  
 
Measuring glycaemic control 
Glycaemic control is measured by a blood test, HbA1c. The current acceptable HbA1c 
levels are <7%, according to the American Diabetes association (ADA).44 HbA1c is 
used as a marker of the level of glycation (previously referred to as glycosylation) of 
haemoglobin. It was first used 25 years ago and has since played a role in the 
prediction and prevention of diabetic complications.43 Glycation refers to the process 
whereby chemical linkage of glucose onto proteins, through amino groups, occurs.43 
The extent of glycation depends on the level of exposure to glucose and is 
expressed as a percentage of the total HbA1c. It has been shown that the level of 
HbA1c is a reflection of the level of glycaemia over the past 3 to 4 months.43  
Recommended practice in South Africa’s public sector follows the ADA guidelines44 
whilst some private sector recommendations follow the International Federation of 
Diabetes (IFD) guidelines. According to the national guidelines* for control and 
management of diabetes type 2 at primary level,27 in South Africa,  HbA1c levels are 
 
 
                                                             
*  At the time of the study, primary care facilities were guided by the National Guidelines 27 issued in 2004. The revised version 
was being finalised when this study was undertaken. 
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divided into three categories: optimal (normal HbA1c); acceptable (< 2% points above 
normal); compromised (> 2% points above normal). These guidelines recommend 
that all diabetic patients have an annual HbA1c test.  
 
Influences on glycaemic control 
Efforts to improve the quality of management of diabetic patients should be informed 
by knowledge of factors that influence glycaemic control and how these factors act 
as barriers or facilitators. Describing and determining factors that may influence 
glycaemic control enables planning and ensures better intervention programmes for 
diabetic patients with poor glycaemic control, in the future. 
 
The Wagner Chronic Care Model, developed by the MacColl Institute for Healthcare 
Innovation more than a decade ago,37,45 served as a basis for identifying factors to 
be investigated in this study. The model is a widely adopted approach to improving 
chronic care that has guided clinical quality initiatives in the United States of America 
and around the world. The basis of the model is to encourage better interactions 
between the patient and his/her healthcare team. The elements of the model are: 
clinical information systems; decision support; self-management support; delivery 
system design; the community and organisational leadership. The model describes 
how these elements work together to create a patient-centred, health care team and 
summarises the basic elements for improving chronic care in health systems at the 
community, organisation, practice and patient levels.37 Based on this model, in this 
study, barriers that impair patients' ability to achieve good glycaemic control were 
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described from a patient, health facility and health professional perspectives (Figure 
1.1). 
 
   
 
 
 
 
 
 
 
 
                                                                                                                                                                                     
 
 
 
Figure 1.1 Illustration of factors investigated in this study as influences on glycaemic control 
 
2.1.1 Patient related factors  
Recognised predictors of good glycaemic control in diabetic patients include 
compliance with medication,46 physical activity levels,47 compliance with dietary 
advice,38  clinic attendance,25 diabetes education,25 existing co-morbidities as well as 
Health system factors 
Organisational systems 
Dedicated diabetic clinics 
Detection of defaulters
Clinic guidelines 
Medicine supply 
 
Healthy diabetic 
patients with 
minimal /no 
complications 
Good 
Glycaemic 
Control 
Patient factors 
Knowledge 
Culture 
Beliefs 
Attitude to health 
Health seeking 
behaviour 
Compliance 
Age 
Sex 
Health care professional 
factors 
Continued education 
Knowledge and skills 
Awareness 
Motivation 
Staff shortage 
Financial resources lacking 
 
  
11 
 
age and sex.25  Factors such as a person’s attitude to health, as well as their health 
seeking behaviour may be influenced by one’s knowledge, culture and beliefs.48  
 
Studies have shown that diabetic patients, who have an adequate knowledge about 
their disease and who receive regular counselling are most likely to have better 
glycaemic control.49  Poor health literacy (a patient’s ability to read, comprehend and 
act on medical instructions) is common among patients who have attained lower 
levels of education.50  A study in San Francisco found that most patients with chronic 
medical conditions such as type 2 diabetes, asthma and hypertension had 
inadequate health literacy. This was independently associated with poor glycaemic 
control in diabetics and was found to disproportionately add to the burden of 
diabetes among the lower socio-economic populations.50 A South African study 
showed that patients are not sufficiently educated about diabetes and thus are 
unable to manage their own disease well.33 A study that researched dietary 
compliance in South African type 2 diabetics found that patients with low health 
literacy were unable to follow nutrition advice, especially when this advice was 
presented in ways that did not relate to the patient’s cultural environment and in 
ways that were not easy to comprehend.38   
 
Compliance with medication is a key component of self management of diabetic 
patients and increased compliance is associated with substantial improvements in 
glycaemic control.51-52 Plausible patient challenges in adhering to diabetes 
medication include, poor patient education, therapy with multiple drugs, believing 
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one has diabetes only when one’s sugar is high, worrying about side-effects of 
diabetes medication, lack of self-confidence in controlling diabetes and feeling 
medicines are hard to take (difficulty reading prescription labels).53 Some of these 
challenges are potentially modifiable and should be targeted for educational 
interventions to improve diabetes outcomes. 
 
According to the American Diabetes Association, home blood glucose monitoring is 
a component of effective therapy to achieve good glycaemic control in insulin 
dependent diabetics. Self monitoring of blood glucose allows patients to evaluate 
their individual responses to therapy and to assess whether they are achieving their 
glycaemic targets.58  
 
Socio-economic factors play a role in diabetes outcomes including glycaemic control, 
morbidity and mortality.56 Two population based studies from Sweden showed that 
diabetic patients who had poor glycaemic control showed characteristics of a lower 
social class position.54,55 A hypothesis on the relationship between social status and 
health is highlighted in an article by Wray et al.57 The authors argue that increased 
education levels would improve occupational prospects, resulting in higher incomes, 
which would result in improved health outcomes through safer and less stressful 
workplaces, greater access to health literacy and information and better social 
networking. One of these studies showed that lower social class, which was defined 
by economic groups according to employment, correlated with poorer glycaemic 
control irrespective of the person being foreign or Swedish national. These studies 
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highlighted that socio-economic class may have an influence on the onset or course 
of diabetes and may also impact on compliance to medication. Socioeconomic status 
has also been identified as an important factor influencing physical activity levels.58 
Lower socio–economic status was found to be related to poorly controlled diabetes 
but also to higher rates of obesity and hyperlipidaemia.11 
 
Obesity has been considered a major risk factor for the development of type 2 
diabetes. The basic metabolic abnormality of both diabetes and obesity is resistance 
of peripheral tissues to the action of insulin. Increasing levels of obesity and insulin 
resistance have been associated with poorer glycaemic control.61-62 Cultural beliefs 
may play a role in obesity. This is particularly of significance in South Africa, where 
HIV/AIDS is associated with being underweight. Obesity on the other hand is asso-
ciated with a feeling of authority, affluence and well-being.63  
 
Regular physical activity is associated with a reduced risk of numerous chronic 
conditions and premature mortality.64 The results of a meta-analysis by Boulé et al65 
showed a 0.66% reduction in HbA1c in a group that exercised and this finding 
supported the theory that exercise improves glycaemic control in patients with 
diabetes. This study showed that exercise does not need to reduce body weight to 
have a beneficial impact on glycaemic control. In a study presented at the European 
Congress of Endocrinology in Germany 2007, looking at women with type 2 
diabetes, it was found that systematic exercise combining both aerobic and strength 
training significantly improved oxygen consumption, power and muscle strength and 
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thus had benefits on glycaemic control.66 Exercise training decreases hepatic and 
muscle insulin resistance and increases glucose disposal through mechanisms that 
are not associated with weight changes. A primary benefit of exercise for non-insulin-
dependent diabetes mellitus (NIDDM) is the effect it has on reducing blood 
cholesterol, triglyceride levels, and body fat.64  
 
A study in SA found that poorly controlled black diabetic patients were also  
hypertensive, obese and with dyslipidaemia.38 Although no direct relationship 
between co-morbidity and poor glycaemic control has yet been established, it is 
important to bear in mind the possibility that co-morbidity may contribute to 
glycaemic control indirectly. Dyslipidaemia (which comprises hypertriglyceridaemia 
and reduced HDL cholesterol) cannot be attributed to being an influence on 
glycaemic control, but it is associated with poor control in diabetics.67 A study in 2001 
by El-Kebbi et al68 showed that co-morbidity did not appear to limit achievement of 
good glycaemic control in patients with type 2 diabetes. However, a study by 
Odegard et al53 in 2008, showed that good glycaemic control was considered more 
difficult to achieve in diabetic patients with co-morbid diseases, as a result of poorer 
adherence. 
 
The reasons behind the relationship between age and glycaemic control remain 
unclear. A Tunisian study, with 94% of its study population having type 2 diabetes,  
found that younger patients are generally better at managing their glycaemic 
control.25 However a study conducted amongst 15 Native American Indian tribes, the 
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Strong Heart Study, which investigated both type 1 and type 2 diabetes,  found that 
younger individuals had the worst glycaemic control.69 Although the finding of poorer 
control amongst younger patients was suggested to be due to the poor compliance 
noted in this age group, the possibility of survival bias, in that patients with higher 
HbA1C levels may die at a younger age, could not be ruled out.69 Other studies52,68 
however, have shown that older patients tend to keep their follow-up appointments 
more regularly than younger patients, and those who keep their appointments are 
able to achieve better glycaemic control.  
 
Another finding from the Strong Heart Study was that women had worse glycaemic 
control than men.69 Misra and Lager also mention numerous studies in the US which 
have found that diabetes related complications are more common in women and 
minority populations.70 
 
A study undertaken in the UK showed that monotherapy (insulin or sulfonylurea or 
metformin) increased the proportion of patients who had good glycaemic control 
when compared to diet modifications alone.62 However it was found that after three 
years, at least 50% of patients on monotherapy would have a deteriorating level of 
glycaemic control and by nine years, only 25% of patients on monotherapy are still 
controlled. The majority of diabetic patients are thought to need multiple therapies to 
attain good glycaemic control over time in keeping with the theory that β-cell function 
progressively deteriorates with time.18 
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2.1.2  Health care professional related factors 
 
Caring for patients with diabetes is a complex process and this is reflected in the 
multiple potential factors that can affect the quality of care highlighted in previous 
studies.14,17,25,31,71-73 Health care professionals can play a very important role in 
managing diabetic patients. In order to improve the care of diabetic patients, it is 
essential to determine the obstacles that these providers face.  
 
Whilst some studies have identified issues such as the sex of health care 
professionals as well as their motivation levels as possible influences on their 
management of diabetes17,25,73-74 a study by Steyn et al30 identified that one of the 
main factors affecting doctors and nurses ability to provide optimal diabetes 
management, was staff shortage and the fact that the resultant high patient load 
prevented quality of care.  
 
Reinforcement of the need for comprehensive care of diabetes patients, awareness of 
complications, adequate training, guideline implementation and good supervision are 
all essential in managing diabetic patients.33 As part of comprehensive care, 
healthcare professionals need to offer counselling on diet and lifestyle modification as 
well as ensure that patients are well educated about their disease. It is important that 
these personnel are adequately trained to perform these tasks. The study that 
researched dietary compliance in South African type 2 diabetics also showed that 
although some health care professionals offered dietary counselling, these 
professionals had little training in nutrition and knowledge of foods that are 
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traditionally eaten.38 This study highlighted that inadequate and inaccurate dietary 
counselling given by healthcare professionals can influence glycaemic control.38 The 
quality of diabetes education received from healthcare professionals has been shown 
to influence glycaemic control.15 Studies in the Western Cape, looking at the quality of 
care received by patients at the primary care level, showed that clinical examinations 
to detect treatable diabetic complications were inadequately done by health care 
providers.30,32 
 
Healthcare staff training has been identified in numerous studies as a factor that may 
influence glycaemic control.17,25,73-74 Nurses play an important care giver role in the 
primary care setting in South Africa. However despite this important role that they 
undertake, chronic diseases are not extensively covered in their training.36 As a 
result South Africa nurses often lack skills to intensively deal with chronic 
diseases.36,41,75-76 In addition to basic training continued education and a need for 
regular assessment of these health care providers’ knowledge and skills regarding 
diabetes is essential.33 
 
Steyn et al30 also highlighted that health professionals felt that they were restricted in 
performing special investigations due to a lack of financial resources at primary care 
facilities. 
 
The implementation of simple protocols as well as in-service training was shown to 
be likely to improve glycaemic control and diabetic outcomes at primary care sites.32 
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The use of guidelines ensures standardisation of care and improves patient 
outcomes.72 In South Africa, studies have highlighted that although National 
Department of Health’s guidelines for hypertension and diabetes care exist,  
guideline implementation remains a significant problem39,41 In addition healthcare 
staff referred to the guidelines infrequently. 
 
Barriers identified, locally and internationally,39,41,72 to guideline adherence are: 
 Need for education on the disease  
 Need for education on guideline usage 
 Lack of time 
 Lack of confidence in clinical skills 
 Complexity of the disease 
 Scepticism about the guidelines 
 Conflict with known practice 
 Conflict with patient beliefs 
 
2.1.3  Health facility related factors 
The 2003 South African Health Review29 showed that more patients attended public 
rather than private health care facilities for chronic disease management. Even 
though the public and private sectors in South Africa are of comparative size in terms 
of overall expenditure they cater for significantly varying population sizes. The public 
health care system is overburdened and under-resourced, often leading to 
overcrowded clinics, inadequate number of staff, high patient loads, short 
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consultation time and poor record keeping.  A huge burden is placed on these public 
health facilities and may contribute to the quality of care delivered to chronic disease 
patients.  
 
The effective management of chronic diseases is dependent on well managed health 
facilities. Some goals of a well managed facility include controlling cost, improving 
access and assuring high levels of quality of care provided to those attending the 
facility.  
 
South African studies have shown deficiencies in health care delivery to people who 
attend public primary care facilities for chronic disease management.12,26 One of 
these studies, in 1998, showed that only a third of patients with diabetes managed at 
the primary care level were in fact well managed.26  
 
Health facility related factors found to influence diabetes care include the presence 
of a dedicated diabetic clinic, a recall system or system to detect defaulters, 
reminder systems, availability of clinic guidelines, an uninterrupted supply of 
medication, insulin and the syringes needed as well as education programs.25  
Dedicated chronic disease clinics were introduced following a study in Tunisia, and 
were found to be a major success in improving the quality of care of diabetes.25 The 
absence of organisational systems to support diabetes management can be a 
leading influence in glycaemic control.72    
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1.5 Purpose of the study 
Aim 
To determine factors that influence glycaemic control in diabetic patients attending 
three selected Community Health Centres (CHCs) in the Johannesburg metropolitan 
health district (JMHD), in Gauteng, with the view to enabling health care managers 
improve the quality of services and management of diabetic patients.  
 
 Objectives 
1. To determine the proportion of diabetics attending at the CHCs who are well 
controlled as measured by an HbA1c test.  
2. To describe the factors that influence glycaemic control in diabetic patients -: 
2.1   Patient related factors 
2.2   Health care professional related factors  
2.3   Health facility related factors 
3. To determine patient related factors that influence glycaemic control in 
diabetic patients. 
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CHAPTER TWO  
2.0 METHODS 
This chapter describes the methods used to conduct this study.  The study design, 
setting, and the sampling strategy are described.  Descriptions of data collection as 
well as the methods of data analysis are included.  
 
2.1 Study Design  
A cross sectional analytical study design was used for patient related factors. Primary 
data collection involved patient interviews and well as anthropometric measurements 
and blood tests. A six month retrospective review of these patients’ records was also 
undertaken. Health care professionals and facility managers were interviewed. Health 
care professional and health facility factors were described only.  
 
2.2 Study Setting 
Three Community Health Centres† (CHCs) from the Johannesburg Metropolitan 
Health District (JMHD) were selected for the setting of this study. The Gauteng 
Provincial Health Department (GDoH) has chosen, for management purposes, to 
 
 
                                                             
† Community Health Centres (CHCs) are primary care facilities that provide comprehensive services including promotive, 
preventive, rehabilitative and curative care. Casualty and maternity services are available as 24-hour services. Community health 
services are part of a coordinated District Health System. 
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divide the province into districts which are co-terminus with the local government 
areas. JMHD is a large urban metropolitan district with a population of approximately 
3.2 million people.12 This District is subdivided into 7 administrative sub-districts 
(regions), referred to as A-G ( Figure 2.1).  
 
Figure 2.1 Map of the Johannesburg Metropolitan Health District showing sub-districts A to G75 
 
The JMHD has approximately 107 primary health care facilities of which ten 10 are 
CHCs. All of the CHCs are administered by the Provincial Health Department with the 
exception of Alexandra CHC which is managed by a non-Governmental Organisation 
(NGO). 
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District Health Information System (DHIS) data shows that 40% of all diabetes patient 
visits between April 2007 and March 2008, to primary care facilities in the public 
sector, were to CHCs in Gauteng for the period.78 In view of the high proportion of 
patients seen in such a limited number of facilities, CHCs were chosen as the study 
setting.   
 
Historically, the population groups in South Africa lived in racially defined areas. 
Clinics that served the various areas were managed differently and these divisions 
persist. Because of these underlying divisions, selecting one CHC from each of the 
sub-districts would ensure demographic representation. All CHCs in the JMHD were 
ranked according to the number of diabetic patient visits during the period               
April 2007 - March 2008 (DHIS data) and the provincially run CHCs with the highest 
number of diabetic patients seen in each region were selected (Table 2.1). 
 
Table 2.1 Data for provincially run Community Health Centres in the Johannesburg Metro Health 
District, summarised from District Health Information System for period April 2007- March 200876 
Region CHCs Total number of diabetic 
patient visits to CHC        
April 07-Mar 08 
Rank  
Region C Discoverers 8210 6 
Region D Zola 19148 1 
 Chiawelo 17970 2 
 Itireleng 12259 3 
 Mofolo 12048 4 
 Lilian Ngoyi 4364 7 
Region F Hillbrow 10886 5 
Region G Lenasia South 3729 8 
 Stretford 1042 9 
                        * There are no CHCs in regions A , B or E.  
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Two CHCs were excluded from the selection process as they were considered to be 
potential sources of bias.  
 Zola CHC (Region D) was excluded because an intervention study, looking at 
improving diabetic care had already been undertaken at this clinic. A Chronic 
Disease Outreach Program (CDOP) based on the chronic care model involved 
follow up of patients with diabetes mellitus and hypertension and provided 
support to primary health care nurses, to improve health systems for 
management in Soweto.9 The program has had an impact on the knowledge of 
healthcare staff involved in the program as well as improved the early detection 
and referral of high risk, poorly controlled diabetic patients. 
 Hillbrow CHC (Region F) was excluded because most of the attending diabetic 
patients had been down referred from Johannesburg Hospital during 2007, 
when the restructuring of tertiary services came into effect. The care provided 
at this tertiary institution was assumed to be optimal and including these 
patients would not reflect the management of diabetes at a primary care facility. 
 
The selected CHCs were therefore -: 
A. Chiawelo Community Health Centre (Region D) 
B. Discoverers Community Health Centre (Region C) 
C. Lenasia South Community Health Centre ( Region G) 
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2.3 Study Period 
Data collection took place between the 18 November and 11 December 2008. There 
were no public holidays during this period. The CHCs had specific days on which 
diabetic patients were seen and each CHC was visited four times (Table 2.2).  
 
                   Table 2.2 Diabetes clinic days at Community Health Centres 
CHC Diabetic Clinic Days Dates visited during 2008 
Chiawelo Tues, Wed 18/11, 19/11, 25/11, 09/12 
Discoverers Thurs 20/11, 27/11, 04/12, 11/12 
Lenasia South Tues, Wed 26/11, 02/12, 03/12, 10/12 
 
 2.4 Study Population 
Objective 1 and 2.1 
For objectives 1 and 2.1 the study population included all diabetic patients                   
(Type I/Type 2), 18 years of age and older, who attended one of the three clinics, for 
diabetes care during the study period.  
 
Exclusion criteria: 
 Patients less than 18 years of age 
 Those with dementia or severe psychiatric illness. 
 Those who were diagnosed as having diabetes less than 6 months prior to their 
clinic visit during the study period. Six months was considered to be too short a 
period to draw conclusions regarding glycaemic control.  
  
26 
 
 Those patients who had attended the CHCs in which they were seen for less 
than six months. These patients would not have attended at the CHC long 
enough for conclusions to be made about health facility factors that may 
influence their care. 
 
Objective 2.2 
The study population for objective 2.2 was all nursing staff and doctors who provided 
care to patients with chronic diseases, including diabetes, in the selected CHCs during 
the study period. 
 
Exclusion criteria: 
One of the factors that may have an impact on glycaemic control is clinical practice, 
therefore the following staff were excluded as they would not have been in the system 
long enough to comment on staff related factors that could influence the glycaemic 
control of patients: 
 Health professions employed at the CHC for less than 6 months 
 Agency/locum (temporary) staff 
 
Objective 2.3 
The CHC managers were interviewed. Data were also collected by reviewing patient 
records.   
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2.5 Sampling  
A sample size of 385 was calculated for this study based on the following 
assumptions: 
 
  50% of patients would have controlled glycaemia,29  
  the true proportion of patients who have controlled glycaemia would be 
estimated to within 5%, and  
  the proportion of patients who have controlled glycaemia would be estimated 
with 95% confidence. 
This sample size was calculated to have sufficient observants to fit a logistic 
regression model accommodating 25‡ independent factors (explanatory variables). 
 
The aim was to sample approximately 420 patients (this was approximately a 10% 
overestimation of the required sample size of 385). Patients were systematically 
sampled. Patients were excluded if any of the exclusion criteria were fulfilled. Analysis 
was only conducted on those records that had a measureable outcome (i.e. HbA1c 
result). 
 
 
 
                                                             
‡ It is recommended that approximately 10-15 subjects per variable is necessary when performing logistic 
regression59. 
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The number of patients that needed to be interviewed per day in each clinic was 
estimated. As Chiawelo had twice as many patient visits than the other two CHCs 
(Table 2.1) 50% of the study population was taken from this CHC. Therefore 210 
patients (approximately 55 patients per day) were to be selected at Chiawelo CHC. 
Chiawelo CHC sees between 150-180 diabetic patients per day and every third patient 
was sampled starting from a random number between one and three.  
The aim was to sample 100 patients each from Lenasia South and Discoverers CHC 
as they both indicated that they saw between 40 to 50 patients per diabetic clinic. At 
Lenasia South and Discoverers CHC a sample size of 25 to 30 per day was required. 
As both CHCs see between 40 and 50 patients per day, every second patient was 
sampled.    
 
In all three clinics, if a patient did not give their consent to participate the next person 
was selected.  
 
2.6 Data collection 
Primary data were collected by the principal investigator and two research assistants 
(interviewers), which included a registered professional nurse. Research assistants 
were trained by the principal investigator during a half day workshop to ensure that 
questions were well understood and minimal inter observer variability occurred. The 
research assistants were fluent in local languages and conducted all interviews on 
patients who did not speak English. The principal investigator conducted all facility 
manager and healthcare staff interviews.  
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Data collection tools were developed for this data collection (Appendices D-G). All 
research tools used in this study were developed by reviewing the literature on factors 
influencing the care of diabetics and factors influencing glycaemic control.17,25,30,38,46-
48,57,66,70 This literature search focussed on primary care and was conducted using 
Pubmed and included years from 1990 onwards.  Studies reviewed were restricted to 
those involving humans and published in English. The literature review identified many 
articles that reported similar factors relating to achieving good glycaemic control and 
only relevant articles have been referenced for this study.  
 
2.6.1 Patient related data 
The movement of diabetic patients through the diabetes clinic is illustrated in Figure 
2.2 below. 
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                * Urine dipsticks were used to test for both glycosuria as well as proteinuria 
Figure 2.2 Flow diagram of patient movement through diabetes clinic during study period  
 
Patient information was obtained by interviewing the patients and by reviewing the 
patients’ medical records to look at their management over the past year as recorded 
in their notes. The patient interview contained questions about socio-demographic 
factors, disease related factors, co-morbidity related factors, and some behavioural 
factors. A standardised questionnaire was used for the interview process (Appendix D) 
Registration  with 
administration 
clerk 
Routine measurements 
done by nursing assistant: 
pulse, blood pressure, 
urine*, random blood 
sugar. 
Seen by nursing staff 
for routine  appointment 
(medication dispensed 
simultaneously) 
Sticker issued 
if sampled for 
study 
Inclusion in study if 
randomly selected 
on arrival 
Consent 
Study Interview 
Bloods taken  for: 
HbA 1
c 
and  Lipid 
profile. 
Review of records 
Body Measurements: 
Weight, height, waist 
circumference. 
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and a data collection tool (Appendix G) was used to collect data from reviewing the 
records. Each patient also underwent blood testing and body measurements.  
 
Clinical Measurements 
Some of the measurements, blood pressure, random blood glucose and urine 
dipsticks, form part of the routine management for patients with diabetes and were 
conducted by nursing staff at the selected CHCs. The remainder of the 
measurements, height, weight and waist circumference, were conducted by the 
principal investigator. 
 
Weight, height, and waist circumferences were measured while the patient was 
wearing light clothes, having removed heavy jackets. Weight was taken to the nearest 
0.5 kg, and height and waist circumference was taken to the nearest 0.5 cm.  
 
Blood pressures were measured by nursing staff with a sphygmomanometer. The 
measurement was done while the patient was in a sitting position with the arm at the 
level of the heart after 5 minutes of rest. 
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Random blood glucose, a fingerprick sample, was measured using the Accu-Chek§ 
glucometer at all study sites.  
 
Blood tests 
Blood samples were collected from each patient with their permission by either the 
principal investigator or a phlebotomist. The National Health Laboratory Services 
(NHLS) are contracted by the GDoH.  The samples taken during this study were sent 
to and analysed by the NHLS laboratories that serviced the respective CHCs. All of 
the above tests were measured according to the same reference ranges by the 
different NHLS laboratories. Whilst diabetic patients at all three CHCs are asked to 
arrive for their routine appointments in a fasting state, it was difficult to verify if this was 
true for all patients. The tests conducted during this study, taken on the day of the 
interview, are highlighted in Table 2.3. 
 
 Table 2.3  Blood tests conducted during this study 
Test Rationale 
HbA1c As a measure of glycaemic control 
Lipids ( total cholesterol and lipid profiles) To assess presence of hypercholesterolemia 
 
 
                                                             
§ Accu-chek is the brand of blood glucose-testing devices (glucometers) manufactured by Roche Diagnostics. Kits consist of an 
electronic monitor which measures blood glucose via inserted one-time-use "strips" and a lancet device which fires a sharp 
needle marginally through the epidermis of the finger in order to allow a small amount of blood to be squeezed onto the strip in 
the monitor. 
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Details of laboratories and methods utilised for blood testing are provided in           
Appendix C.  
The NHLS Thusano Database was reviewed to determine if patients included in the 
study had previously had a blood test for HbA1c.  
 
2.6.2 Health Professional Data 
Health care professional interviews were conducted face to face, using the health care 
professional questionnaire (Appendix E). Questions related to the number of years 
since qualifying, time employed at the CHC, knowledge about basic diabetes care, 
knowledge of normal ranges of blood tests relevant to diabetes care, continued 
diabetes education, challenges experienced whilst working in the diabetes clinic, and 
their perception of their skills were posed. These questions were a combination of both 
closed and opened ended types. 
 
2.6.3 Facility Related Data 
Information on each health facility and the possible factors that might influence 
glycaemic control were collected by: 
 Face to face interviews with clinic managers using the ‘Health Facility Review’ data 
sheet (Appendix F). As part of the health facility manager interview, enquiries were 
made about whether the facility had a dedicated diabetic clinic, whether an 
appointment system and a system to detect defaulters existed at the facility for 
diabetes clinics. The interview also involved collecting information on the systems 
that existed for ensuring good quality diabetes care.  
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 The availability of equipment needed for comprehensive diabetes care at each 
facility was assessed with a separate data collection sheet (Appendix H). 
The following equipment was looked at in terms of the total number present at 
each clinic, as well as total number in working condition: 
 Weighing scales 
 Glucometers 
 Sphymanometers (Blood pressure machines) 
 ECG Machines and the availability of ECG paper 
 Snellens Charts 
 Height Scales 
 Fundoscopes - battery availability and functioning light 
 Tape Measures 
 
Data from patient interviews from closed questions on patient satisfaction with overall 
care received at the facility and accessibility were also used in describing health 
facility related factors.  
2.6.4 Study Variables  
 
Table 2.4 A list of objectives and variables utilised in the study 
OBJECTIVE VARIABLES 
1.  To determine the level of        
glycaemic control of diabetes 
at the selected CHCs 
HbA1c <7  = Good glycaemic control 
HbA1c ≥7 = Poor glycaemic control 
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2.1 To determine patient factors   
      influencing glycaemic control 
 
Demographic Characteristics: 
Gender 
Race 
Age  
Employment status 
Education level 
Socio-economic score 
Disease related characteristics: 
Type of diabetic treatment 
Time since diagnosis 
Length of time attending CHC 
Self reported compliance with medication 
Co-morbid conditions: 
Hypercholesterolaemia 
Dyslipidaemia 
Hypertension 
Obesity 
Behavioural/lifestyle Characteristics 
Alcohol consumption 
Physical activity levels  
Fruit and vegetable consumption 
2.2 To determine health care     
      professional factors      
      influencing glycaemic control 
Demographic information of health care professional 
Level of qualifications and training specific to diabetes 
Perceived work load 
Attitudes to diabetes management 
Challenges faced by staff in working in chronic disease clinics 
Patient perceptions about education on diabetes received 
Patient perceived satisfaction with diabetes care 
National diabetic guideline adherence 
Perceived level of own diabetic management skills  
2.3 To determine health facility 
related factors that influence 
glycaemic control 
 
 
 
Patient satisfaction  with service delivery  
Presence of dedicated chronic diseases clinics 
Staff complement overall and  in diabetic clinic 
Total number of patients seen at clinic – overall and in diabetic 
clinic 
Total number of patients seen in the chronic disease clinic 
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2.7 Data management 
Data were coded and captured using Epi-info version 3.5.1 and stored in a Microsoft 
Access database. To protect the integrity of the database, the Microsoft Access 
database was write-protected and stored, whilst copies of the database were used for 
analysis. For the purposes of descriptive analysis this data were exported to Microsoft 
Excel as well as STATA version 10. STATA version 10 was utilised for all other 
analysis. Data were verified with the original interview scripts to exclude duplicate 
records and errors. Data cleaning for all fields was conducted by looking at data 
ranges as well as outliers.   
Managing variables  
Some variables needed to be defined or calculated before they could be analysed. 
These were as follows: 
 Demographic characteristics: Age was measured as a continuous variable. 
Patients were categorised as Black African, Coloured, Indian, or White.            
For purposes of data analysis the variable for level of education attained was 
classified into three main groups: “no formal education”, “completed secondary 
 
 
Total number of new diabetics 
Total number of diabetic follow ups per month 
Presence or absence of system to detect defaulters 
Availability of diabetes guidelines 
Availability of diabetic drugs at the facility  
Method used to diagnose diabetes 
Good record keeping at routine visits 
Prior assessment of glycaemic control via HbA1c 
Referrals for -Health promotion 
                     -Dietician review 
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education” and “did not complete secondary education.” As the number of 
patients with tertiary education was relatively small, they were combined with 
those that had completed secondary education.  
 Disease related characteristics: To determine the variable length of time as a 
diabetic, the difference between the dates of the patients study interview and 
date of diabetes diagnosis was used. Attendance at the study CHC was 
determined by the difference between the year the study was conducted and 
the year the patient reported having started diabetes clinic attendance at the 
CHC. Patients were classified as ‘compliant’ if they reported that they did not 
miss their medications more than once in a month and “non-compliant” if they 
missed their medications more than once in a month. 
 Co-morbid conditions 
For descriptive purposes co-morbid disease variables were categorised 
according to the National Department of Health guidelines (2004) in South 
Africa, which were in effect at the time of the study.27 In the univariate analysis 
these variables were used as continuous variables. Table 2.5 shows the co-
morbid variables and their categories. 
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                  Table 2.5  Categorisation of variables used to describe co-morbid factors 
Variable Categories 
Blood pressure Optimal < 140/90                                                   
Acceptable ≥ 140/90 and < 160/95                             
Compromised (high risk) ≥ 160/95 
Lipid Profile: 
Total Cholesterol 
 
 
                                                                                     
Optimal (< 5.2 mmol/L)                                   
Suboptimal (≥ 5.2 mmol/L < 6.5 mmol/L) 
Compromised (≥ 6.5 mmol/L) 
HDL-Cholesterol  
 
 
Optimal  (≥ 1.1 mmol/L)                                       
Suboptimal  (≥ 0.9 mmol/L < 1.1 mmol/L) 
Compromised (< 0.9 mmol/L) 
LDL-Cholesterol 
 
Optimal (< 2.6 mmol/L)                                          
Suboptimal (≥ 2.6 mmol/L < 3.4 mmol/L) 
Compromised (≥ 3.4 mmol/L) 
 BMI (kg/m2) 
 
Optimal   > 18.5 < 25                                                
Suboptimal 25-27                                        
Compromised > 27 
 
Hypertension was considered to be present if the patient was being treated with 
anti-hypertensive drugs and/or self reported that he/she was a known hypertensive.  
Patients were considered to have dyslipidaemia if they were receiving lipid lowering 
drugs. Body mass index (BMI), used to determine control of body weight, was 
calculated as weight in kilograms divided by height in meters squared. BMI greater 
than or equal to 30kg/m2 was considered obese. Internationally BMI is categorized 
as normal if BMI was <25 kg/m2, overweight if BMI was 25–29.9 kg/m2, and obese if 
BMI was ≥30 kg/m2 (World Health Organization, 1995).  
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 Socio- economic Indicator Score 
A score was used to reflect the socio-economic status of participants. This 
score was formulated from nine assets (electricity, television, fridge, radio, 
microwave, video machine/DVD player, washing machine, telephone, motor 
vehicle). Each asset contributed one point towards the score and the study 
socio-economic indicator score thus ranged from 0 - 9 (poorest-richest). Factors 
contributing to the socio-economic indicator score were adapted from a study80 
which identified assets as significant contributors to the socio-economic score 
through a factor analysis.   
 
 Behavioural Factors 
-A patient was considered to be an alcohol consumer if a minimum of one unit 
of alcohol was consumed at least once a week by the participant.  
 
- Physical activity was estimated by considering all physical activity undertaken 
by the patient in a one week period. The physical activity section of the study 
questionnaire was based on the International Physical Activity Questionnaire 
(IPAQ) short form. The IPAQ short form is an instrument designed primarily for 
population surveillance of physical activity among adults and has been tested 
and validated for use in adults’ aged 15 - 69 years.79 Patients were asked about 
the amount of vigorous activity, amount of moderate activity, waking and sitting 
undertaken by them in the week preceding the study interview. Patients were 
asked to report the duration in minutes per day that each of these activities 
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were performed as well as the total number of days per week that they would 
undertake such activity.   
Physical activity was scored using a metabolic physical activity score by 
weighting the intensity (multiples of basal metabolic rate (METS)) by the 
duration (h/wk) of each of the activities that data had been collected for. The 
selected MET values** were derived from the IPAQ Reliability Study undertaken 
in 2000 - 2001 as indicated in the guidelines for data processing and analysis of 
the IPAQ.79 
These scores were divided into three categories81:  
 Category 1: Low. Lowest level of physical activity for all individuals who 
do not meet criteria for the other two categories.  
 Category 2: Moderate. Five or more days of any combination of walking, 
moderate or vigorous activity achieving a total physical activity of at least 600 
MET- minutes/week or three or more days of vigorous-intensity activity of at 
least 20 minutes per day or five or more days of moderate-intensity and/or 
walking of at least 30 minutes/day  
 
 
                                                             
** Walking MET-minutes/week = 3.3 * walking minutes* walking days 
  Moderate MET-minutes/week = 4.0 * moderate-intensity activity minutes * moderate days 
  Vigorous MET-minutes/week = 8.0 * vigorous-intensity activity minutes*vigorous intensity days 
  Total physical activity MET minutes/week= sum of Walking  +Moderate + Vigorous MET-minutes/week        
  scores. 
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 Category 3: High. Vigorous-intensity activity on at least 3 days achieving 
a minimum of total physical activity of at least 1500 MET minutes/week or 7 or 
more days of a combination of walking, moderate-intensity or vigorous-intensity 
activities achieving a minimum total physical activity of at least 3000 MET-
minutes/week.  
 
2.8 Data analysis 
For descriptive purposes, means (together with standard deviation (SD)) were 
reported for continuous variables while proportions (percentages) were reported for 
categorical variables. The number and proportion of patients were recorded for each 
variable within the demographical, disease related characteristics, co-morbid 
conditions and behavioural factor groups. These proportions were described per clinic. 
The outcome factor was dichotomised glycaemic levels (HbA1c <7% and ≥7%). The 
means and proportions of these variables were then compared for well controlled and 
poorly controlled glycaemic groups.  Health care professional factors and health facility 
factors were described only. Means and proportions were used where appropriate. 
Responses to open-ended questions were listed according to common lists.  
 
Chi squared tests, t-tests, or one-way ANOVA were used to assess significant 
differences between means and proportions appropriately. Pearson’s/Spearman’s 
correlation coefficients were used to examine the relationship between numerical 
variables. All inferential analyses were done at an alpha level of 0.05: a value of 
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p<0.05 was regarded as being significant. 95% confidence intervals were reported for 
all estimates. 
 
Univariate and multivariate logistic regression models were used to determine patient 
related factors influencing glycaemic control. To build each model, the crude 
associations between potential factors and good glycaemic control were assessed 
using univariate logistic regression, reporting the unadjusted odds ratios. For adjusted 
analysis, multivariate logistic regression was undertaken, reporting the adjusted odds 
ratios. An initial variable selection (from all the independent variables in the study) was 
carried out to determine which variables could potentially be important in the final 
model. Three methods were used for variable selection to ensure that no potentially 
important variable was left out. These include: a) a plausible relationship with the 
outcome variable b) significant univariate relationship as well as c) exploratory 
automatic variable selection techniques, with probability of entry p<0.1 and probability 
of removal p<0.15.  
 
Variables that were selected from these three selection techniques were used for 
modelling. Those that were significant (p<0.05) in the model as well as those that 
improved the model fit were retained in the final models.  
 
During modelling, the final model was selected from a family of models on the basis of 
parsimony and model fit, using the likelihood ratio test, the area under the receiver 
operating curve (ROC) and the Hosmer-Lemeshow (HL) test of fit.81 The area under 
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the ROC curve lies between zero and one and provides a measure of the ability of the 
model to discriminate between those with good glycaemic control and those with poor 
glycaemic control. A value of 0.5 suggests no discrimination, such that the model is no 
better than random, while values between 0.7 and 0.8 are considered acceptable, 
between 0.8 and 0.9 as excellent and over 0.9 are rare and considered outstanding.81 
The Hosmer-Lemeshow test is used to determine the ability of the model to accurately 
predict the outcome. The null hypothesis for the test says that there is no significant 
difference between the outcome predicted by the model and the data. If the p-value for 
the HL test is greater than 0.05, that means that we cannot reject the null hypothesis, 
indicating that the model is fit and able to well predict the outcome.  
 
2.9 Ethical considerations 
Ethics approval has been obtained for this project (Ethics clearance number: 
M081138) from the University of Witwatersrand Committee for Research on Human 
Subjects (Appendix A). 
 
Information sheets were given to all participants (Appendix I). These information 
sheets were in English only, and the research assistants were able to translate to local 
languages.  All participants provided informed consent. An attempt was made to 
obtain written consent from all patients. Patients who could not read were verbally told 
about the study and placed an X on the consent form. 
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The identity of all participants was kept completely confidential. Patient names were 
only recorded on the consent forms and were never reflected on any of the data 
collection forms. The unique study number allocated to each patient was also 
recorded on the consent forms and was the only method of identifying the patients. 
Only the principal investigator had access to the consent forms which link the study 
numbers to patient names.  Blood test results were received with patient names and 
patient health facility numbers. Consent forms were used to link these names and 
numbers to the study number. This process was conducted by the principal 
investigator only. Once the blood results were entered in the Microsoft Access 
database no further identifiers could link the results to patient names. Only the study 
number was used for identification purposes thereafter. Data was stored in a Microsoft 
Access database and only the principal investigator had access to this data.  
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CHAPTER THREE  
3.0 RESULTS 
 
In this chapter, the study findings are presented. A description of the study 
population and factors influencing glycaemic control, by the three study sites, is 
presented. This is followed by regression analysis of these factors. Thereafter 
findings related to health facility and healthcare professionals are highlighted.  
 
3.1 Introduction 
A total of 418 patients fulfilled the study criteria and were included in the study. 
Those patients that did not have a measurable outcome for the study i.e. an HbA1c 
result was unobtainable (either due to the sample being lost or not done) were 
excluded from data analysis. The final study sample consisted of 394 patients 
(Figure 3.1)  
       
 
 
 
 
 
 
 
 
 
Figure 3.1 Flow diagram of number of cases forming the sample size for this study,  
     Nov-Dec 2008  
Total number of 
patients included in 
the study:               
N=418 
Chiawelo 
CHC: N= 204 
Number of patients 
with HbA1c results: 
N=394 
Discoverers 
CHC: N= 90 
Lenasia South 
CHC: N= 100 
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3.2 Descriptive Analysis of Patient Related Factors 
3.2.1 Glycaemic Control  
Of the 394 participants in this study, only 62 (15.7%) were found to have good 
glycaemic control (HbA1c <7). The median HbA1c (%) was 8.9 (mean ± SD: 9.4 ± 2.4) 
ranging from 4.8%-18.4%. Although the proportion of patients with good glycaemic 
control was low in all three CHCs, Figure 3.2 shows that Chiawelo CHC had a higher 
proportion of diabetics with good glycaemic control than Discoverers CHC or Lenasia 
South CHC (21.6% vs. 7.8% vs. 11.0%; p= 0.007).  
 
Figure 3.2 Glycaemic control per CHC, Nov-Dec 2008 
 
 
Almost 20% of the total population fall into the National Department of Health 
(NDoH) category “not within the target range but at the same time, not requiring 
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additional action” (Table 3.1). Using this classification 64.5% of the study population 
had an HbA1c level that definitely required intervention.  
 
Table 3.1 Glycaemic control at the three CHCs as per NDoH guidelines 
 Chiawelo 
CHC (N=204) 
Discoverers 
CHC (N=90) 
Lenasia 
South CHC 
(N=100) 
Total cohort: 
all clinics 
(N=394) 
P 
value 
HbA1c (%) (Mean ± std dev) 9.0±2.3 9.8±2.4 9.7±2.5 9.4±2.4 0.464 
Good glycaemic control (%)                      
.    HbA1c<7% 
                  
21.6 
                              
7.8 
                     
11.0 
                          
15.7 
           
0.004 
Poor glycaemic control (%)            
not requiring action:                      
m (HbA1c≥7 %< 8%) 
                                     
21.6 
                              
17.8 
          
18.0 
                  
19.8 
Requiring action:                                                
n   (HbA1c ≥ 8%) 
   
56.9 
                            
74.4 
                         
71.0 
                           
64.5 
 
           
0.007 
 
The frequency of HbA1c levels among diabetic clinic attendees is shown in Figure 
3.3. The distribution is uneven.  
 
Figure 3.3 Frequency of HbA1c levels among diabetic Community Health Centre attendees 
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3.2.2 Basic demographic characteristics of the study population 
 
The study population was comprised of 276 females (70%) and 118 males (30%). 
The average age was 58.5 (SD: 11.3) and ranged from 25 years to 88 years. The 
mean age of females was 58.1 years (SD: 11.6) and that of males was 59.5 years 
(SD: 10.5) No significant difference was found between the average age of males 
and females. (p=0.281). Almost one third (30%) of the population was over 65 years 
old (Figure 3.4).   
 
 
Figure 3.24 Age and sex distribution of study population, Nov-Dec 2008 
 
 
Most patients in this study had not completed secondary schooling (86.3%). Only 
9.4% of participants had completed their final year of school and an additional 4.1% 
had a tertiary education (Figure 3.5). 
  
49 
 
 
Figure 3.25 Showing levels of education in the overall study sample 
 
 
Demographic characteristics of the study population in the three study sites are 
shown in Table 3.2. 
 
Table 3.2 Basic demographic characteristics of participants by the Community Health Centres 
 Chiawelo              
CHC         
(N=204) 
Discoverers 
CHC           
(N=90) 
Lenasia South 
CHC          
(N=100) 
Total cohort : 
all clinics   
(N=394) 
P value 
Gender n (%) 
Male                                   
Female 
 
57 (27.9)                  
147 (72.1) 
 
28 (31.1)                   
62 (68.9) 
 
33 (33.0)                    
67 (67.0) 
 
118 (30.0)                  
276 (70.1) 
 
0.640 
Race   n(%) 
Black                                     
Indian                                     
White                       
Coloured 
 
204 (100)                     
0                                
0                                  
0 
 
74 (82.2)                      
5 (5.6)                          
2 (2.2)                          
9 (10.0) 
 
39 (39.4)                  
44 (44.4)                      
1 (1.0)                         
15 (15.1) 
 
317 (80.7)                    
49 (12.5)                         
3 (0.8)                           
24 (6.1) 
 
 
<0.001
Age at time of 
study interview 
(yrs) mean±SD 
                  
60.5±10.9 
(n=202) 
                   
55.7±10.2   
(n=89)  
                  
56.9±12.2  
(n=100) 
                    
58.5±22.3 
(n=392) 
              
0.001 
Employment:                            
Employed n (%) 
                               
48 (23.5) 
                                 
47 (52.2) 
                                
24 (24.0) 
                                   
119 (30.2)                         
    
0.000
Education:                                     
None                           
Some schooling            
Completed 
School  
20 (9.8) 
161 (78.93) 
23 (11.27) 
 
7 (7.8) 
73 (81.1) 
10 (11.11) 
 
9 (9.0) 
71 (71.0) 
20 (20.0) 
 
36 (9.1) 
305 (77.4) 
53 (13.5) 
                  
 
0.675 
Socio-economic 
indicator score 
5.9±2.0 5.8±2.5 6.8±2.4 6.1±2.3 0.005 
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The predominant race was Black African (80.7%). Chiawelo CHCs study population 
was entirely Black African (100%). There was a statistically significant difference in 
the age of participants (p=0.001), distribution of race groups (p<0.001), proportion 
employed (p<0.001) and socio-economic score attained (p=0.005), between the 
three sites. There were no differences between the three sites in terms of gender 
distribution or level of education. 
 
Lenasia South CHC had the highest proportion of participants with higher education; 
the highest socio-economic score as well as a low proportion of patients at this CHC 
were employed. 
 
The mean socio-economic score was 6 (median 7) (Table 3.2). The components of 
this score are illustrated in Figure 3.6 below.  
 
Figure 3.26 Percentages of study participants with access to amenities contributing to socio-
economic indicator score 
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A small proportion (13.2%) scored 9 points (highest possible score) in this asset 
indicator score, with 2.5% and 2.8% scoring just 0 and 1 (lowest possible scores) 
point respectively.  
 
3.2.3 Characteristics related to diabetes. 
 
Relevant diabetes related characteristics are shown in Table 3.3. The mean length of 
time that participants had been diabetic was 9.2 years, ranging from 10 months to 42 
years.  
 
Table 3.3 Diabetes related characteristics of study participants by the various clinics 
 Chiawelo CHC         
(N=204) 
Discoverers 
CHC           
(N=90) 
Lenasia South 
CHC          
(N=100) 
Total cohort : 
all clinics   
(N=394) 
P 
value 
Time since diagnosis 
(years)                                                    
       <5                                                                         
       5-10                                                 
       >10 
                                      
                             
76 (38)
54 (27)                 
70 (35) 
 
21 (24.74)                  
22 (25.29)                    
44 (50.57) 
 
 
24 (24.49)            
33 (33.67)              
41 (41.84) 
 
 
121 (31.43) 
109 (28.31) 
155 (40.26) 
 
             
0.028 
Time attending 
current CHC for 
diabetes care (years) 
mean ± SD 
                             
7.5±.2 
                              
7.3±5.0 
                              
7.4±6.8 
                              
7.4±6.1 
        
0.959 
Type of diabetes 
treatment (%)                          
  Combined therapy                       
Injectable                                         
Oral                 
 
 
22 (10.1)                    
31 (15.3)                        
150 ( 73.9) 
 
 
15 (16.7)                          
24 (26.7)                            
51 (56.7) 
  
 
28 (28.3)                           
14 (14.1)                            
57 (57.6) 
 
 
65 (16.6)                         
69 (17.6)                  
258 (65.8) 
 
             
 
<0.001 
Medication 
compliance n (%)                                       
    Reported compliance                                                                     
                                        
 
159 (78.3) 
                                 
 
73 (81.1) 
                                          
 
75 (75.0) 
                                          
 
307 (78.1) 
    
 
0.732           
 
Overall 65.8%, (N=394) of patients were on oral medication only, with significant 
variation between the clinics.  
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The majority of patients reported that they never forgot to take their medication. The 
response to the question was found to be similar across all three CHCs (p=0.732) 
 
3.2.4 Clinical characteristics 
Table 3.4 gives the clinical characteristics of the study population. Known 
hypertension was noted in 80.8% of patients. Whilst 57.7% (n=394) of participants 
had a blood pressure measurement that was within the recommended target range, 
20.5% (N=394) were considered to require immediate intervention for blood pressure 
control according to the guidelines issued by the National Department of Health.27  
Mean total cholesterol was 5mmol/L with 62.7% having an optimal level. A much 
lower proportion of participants (33.8%) however, had LDL cholesterol results in the 
optimal range.  
 
The mean BMI was 31.3 (SD: 7.1) and ranged from 17.5 - 52 kg/m2. According to the 
international BMI classification, 16% of patients were within the normal BMI range, a 
further 28% were considered to be overweight and 55% of patients were obese.  
The mean waist measurement was 104.6cm (SD: 14.4) (range 69-166cm).  
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Table 3.4 Clinical characteristics of participants by the clinics 
 Chiawelo            
CHC (N=204) 
Discoverers 
CHC (N=90) 
Lenasia South 
CHC (N=100) 
Complete 
sample: all 
clinics (N=394) 
P 
value 
Known to have 
hypertension n (%) 
176 (86.7) 71 (80.7) 69 (69.0) 316 (80.8) 0.001 
Blood Pressure 
Measurement 
Optimal                          
Acceptable                            
Compromised 
138±16.4/85±15 
 
67 (32.8)                            
113 (55.4)                              
24 (11.8)  
143±20.3/85±15 
 
30 (33.3)                                 
52 (57.8)               
8 (8.9)   
143±23.7/80±14 
 
38 (38.0)                                   
46 (46.0)             
16 (16.0)  
140±19.5/84±12 
 
135 (34.3)                         
211 (53.6)          
48 (12.2)  
 
 
0.028
 Total Cholesterol 
(mmol/L) 
Optimal  (<5.2)                        
Suboptimal (≥5.2 <6.5)             
Compromised (≥ 6.5) 
4.9 ± 1.1 
 
132 (64.7)                                          
51 (25.0)                              
21 (10.3)  
4.9 ± 1.1 
 
56 (62.2)                    
27 (30.0)                                  
7 (7.8)  
5.1 ± 1.4 
 
59 (59.0)                                   
29 (29.0)                                     
12 (12.0)  
5.0 ± 1.2 
 
247 (62.7)                          
107 (27.2)                          
40 (10.2)  
 
 
0.229
HDL-cholesterol 
(mmol/L) 
Optimal  (≥ 1.1   )                        
Suboptimal  (≥0.9 <1.1)             
Compromised (<0.9) 
1.2 ± 0.3  
 
130 ( 63.7)                                                  
61 (29.9)                             
12 (6.4)  
1.2 ± 0.4  
 
51 (56.7)      
26 (28.9)                                
13 (14.4)  
1.1 ± 0.3   
 
63 (63.0)                                      
25 (25.0)                                      
12 (12.0)  
1.2 ± 0.4  
 
244 (61.9)                       
112 (28.4)                    
38 (9.6)  
 
 
0.008
LDL cholesterol 
(mmol/L) 
Optimal  (<2.6)                        
Suboptimal  (≥2.6 <3.4 )             
Compromised (≥ 3.4) 
2.9 ± 1.0  
 
72 ( 35.3)                                  
68 (33.3)                             
64 (31.4)  
3.1 ± 0.8  
 
27 (30.0)                                                   
26 (28.9)                       
37 (41.1)  
3.0 ±1.3  
 
34 (34.0)                             
26 (26.0)                                  
40 (40.0) 
2.9 ± 1.0 
 
133 (33.8)                          
120 (30.5)                           
141 (35.8)  
 
 
0.223
BMI mean±SD 
 
Optimal   >18.5 <25              
Suboptimal    25-27       
Compromised >27 
32.3 ± 7.3 
 
22 (10.9)                             
13 (6.4)                               
167 (82.7)  
31.0 ± 6.8 
 
20 (22.2)                               
10 (11.1)                             
60 (66.7)  
29.3 ± 6.5 
 
22 (22.5)                                  
16 (16.3)                                    
60 (61.2)  
31.3 ± 7.1 
 
64 (16.4)                              
39 (10.0)                           
287 (73.6)  
 
 
0.003
 
3.2.5 Behavioural / lifestyle risk factors 
There was no difference between the three CHCs in the proportion of participants 
who consumed alcohol (p=0.345). Overall, 21.6% of participants (Table 3.5) reported 
that they did consume alcohol with 5.6% reporting that they consumed alcohol at 
least once a week.  
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The distribution of physical activity levels was found to be similar in the three CHCs, 
with the overall majority of patients reporting medium physical activity levels 
(p=0.937).   
Fifty percent of the study population consumed fruit less than 3 days in a week whilst 
40% indicated that they ate vegetables less than 3 days a week.  
 
Table 3.5 Presence of lifestyle risk factors  
 Chiawelo 
CHC (N=204) 
Discoverers 
CHC (N=90) 
Lenasia South 
CHC (N=100) 
Total sample 
(N=394) 
P value 
% Alcohol 
Consumption 
39 (19.1) 24 (26.7) 22 (22.2) 85 (21.6) 0.345 
Physical activity 
levels (%) 
Low                                    
Moderate                             
High 
                                        
                            
58 (32.7)                          
78 (44.1)                      
41 (23.2) 
                             
25 (29.4)                               
42 (49.4)                              
18 (21.2) 
 
                              
29 (30.9)                                   
42 (44.7)                                           
23 (24.5) 
 
                              
112 (31.5)             
162 (45.5)              
82 (23.0 ) 
 
                 
0.937
 
 
3.2.6 Markers of glycaemic control 
Forty five percent of the participants (n=178) were found to have glucose in their 
urine (glucosuria) on urine dipstix testing (Table 3.6).  
Of these 178 patients with glucosuria, 94.4% also had an HbA1c result greater than 
7%, and were classified as poorly controlled diabetics (p< 0.001). 
 
A statistically significant difference between the three CHCs was noted in terms of 
random blood glucose fingerprick results (p=0.032). Only 23.4% of the total study 
sample had optimal random blood glucose finger prick results (Table 3.6).  
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Table 3.6 Markers of glycaemic control at the three CHCs 
 Chiawelo 
CHC (N=204) 
Discoverers 
CHC (N=90) 
Lenasia South 
CHC (N=100) 
Total sample 
(N=394) 
P value 
Presence of 
glucosuria (%) 
42% 58% 40% 45% P<0.001 
Random Glucose 
(mmol/l)  
Optimal   (<7)                       
Suboptimal   (7-10)            
Compromised (>10) 
9.9±4.0 
     
55 (21.0)                            
56 (27.5)                             
93 (45.6)  
11.1±4.1 
                          
10 (11.1)                                
32 (35.6)                               
48 (53.3) 
9.7±4.4 
                               
27 (27.0)                                    
34 (34.0)                                   
39 (39.0)  
10.1±4.2 
                   
92 (23.4)                         
122 (31.0)                              
180 (45.7)  
 
 
0.032 
 
 
As shown in Figure 3.7, there was a good correlation between HbA1c and random 
blood glucose concentrations (Spearman’s r =0.51; p<0.001)  
           
Figure 3.27 Relationship between Haemoglobin A1c (%) and random blood glucose (mmol/L) 
 
 
 
5 
10 
15 
20 
0 10 20 30 
Random Blood Sugar (mmol/l)
HbA1c (%) 
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3.3 Risk factors for glycaemic control  
Table 3.7 characterises glycaemic control according to demographic, clinical, 
disease related and behavioural characteristics.  
 
Table 3.7 Proportion of patients with good and poor glycaemic control according to 
demographic, clinical, co-morbid and behavioural characteristics 
Risk Factors Good Glycaemic 
control (HbA1c <7)                
n (%) 
Poor Glycaemic 
control (HbA1c >=7)                     
n (%) 
P value 
DEMOGRAPHIC CHARACTERISTICS 
Gender n (%)                           
Male                                                                
Female 
                                   
24 (38.7)                            
38 (61.3)  
                                               
94 (28.3)                            
238 (71.7) 
                        
 
0.101 
Race   n (%)                        
Black                                                                  
Indian                                                                                                                            
Coloured                                                   
White 
                                    
53 (84.5)                     
8 (12.7)                     
1 (1.6)                       
0 
                                         
264 (79.8)                                                        
41 (12.4)      
23 (7.0)                                 
3 (0.9) 
 
 
 
0.394
Age (yrs) 59.4 ± 11.0 58.3 ± 11.3 0.496 
Employment:                                                                                
Employed                              
Unemployed 
                                  
10 (16.1)                     
52 (83.9) 
                                               
109 (32.8)                         
223 (67.2) 
 
 
0.009 
Education:                                     
None                                                                  
Some schooling            
Completed School  
                                         
4 (6.5)                     
48 (77.4)                 
10 (16.3) 
                                    
32 (9.7)                                              
256 (77.3)                                            
43 (13.0) 
 
 
0.629
Socio economic score 5.9 ± 2.5 6.2 ± 2.2 0.418 
DISEASE RELATED CHARACTERISTICS 
Time  since diagnosis of 
diabetes (years)                                                  
     <5                                                      
     5-10                                               
     >10 
 
27 (44.26)                        
17 (27.87)                         
17 (27.87) 
 
 
94 (29.01)                          
92 (28.4)                           
138 (42.59) 
 
                   
 
0.037 
Length of time attending at 
the CHC                                                
 
6.9 ± 5.8 
 
7.5 ± 6.2 
 
0.458 
Type of diabetes treatment 
(%)                                     
    Combined therapy                                                                            
    Injectable                                                            
    Oral                               
                                    
 
1 (1.6)
9 (14.8)                                   
51 (83.6) 
                                                
 
64 (19.3)                                           
60 (18.1)                                         
207 (62.5) 
 
 
 
<0.001
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Risk Factors Good Glycaemic 
control (HbA1c <7)                
n (%) 
Poor Glycaemic 
control (HbA1c >=7)                     
n (%) 
P value 
Compliance with medication                          
    Yes                                                                             
    No 
                                
 
48 (77.4)                 
14 (22.6)                               
                                           
 
259 (78.3)                                      
71 (21.5) 
 
 
0.895
 
CLINICAL CHARACTERISTICS 
Blood Pressure 
Optimal                          
Acceptable                            
Compromised 
 
21 (60.0)                                   
8 (22.9)                                
6 (17.1) 
 
114 (57.3)                                     
43 (21.6)                                                  
42 (21.1) 
 
0.866
Known Hypertensive  
Yes                                                                         
No 
 
54 (88.5)    
7 (11.5) 
 
262 (79.4)                                      
68 (20.8) 
 
0.096
 Total Cholesterol (mmol/L) 4.8 ± 1.2 5.0 ± 1.2 0.296 
HDL-cholesterol (mmol/L) 1.2 ± 0.3 1.2 ± 0.4 0.373 
LDL cholesterol (mmol/L) 2.7 ± 1.0 3.0 ± 1.0 0.050 
BMI mean±SD 31.9 ± 6.1 31.1 ± 7.3 0.457 
Random fingerprick Glucose 
(mmol/l)  
7.1 ± 2.5 10.7 ± 4.1 <0.001 
BEHAVIOURAL FACTORS 
Alcohol Consumption                   
No                                                                   
Yes                                                                         
                                   
45 (72.6)                        
17 (27.4)
                                             
263 (79.5)                                          
68 (20.5) 
 
0.228
Physical Activity                       
Low                                                                
Medium                                                               
High 
                                 
13 (24.5)                             
30 (56.6)                            
10 (18.9) 
                                               
99 (32.7)                                            
132 (43.6)                                     
72 (23.8) 
 
0.212
 
Participants who were well-controlled had a shorter duration of disease (44.26% <5 
years, p=0.037), were more likely to be unemployed (83.9% vs. 67.2%, p=0.009), 
were on oral medication only (83.6% vs. 62.5%, p<0.00), had lower LDL-cholesterol 
levels (2.7 vs. 3.0mmol/L, p=0.050) and had lower random glucose levels (7.1 vs. 
10.8 mmol/L, p<0.00) than those who were poorly controlled.  
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There was no differences between the well and poorly controlled diabetics (p>0.05) 
in terms of gender, race, age, level of education, socio-economic score, length of 
time attending the CHC, compliance with medication, blood pressure measurement, 
being a known hypertensive, total cholesterol levels, HDL-cholesterol levels, BMI,  
alcohol consumption, or physical activity levels.  
 
3.4 Predictors of Glycaemic control 
Table 3.8 presents the crude odds ratios and 95% confidence intervals of glycaemic 
control for basic demographic factors, behavioural/lifestyle factors, body 
measurements and adherence to guidelines. 
Glycaemic control was significantly associated with unemployment, length of  time 
since diabetes diagnosis, treatment with oral medication only or injectable therapy 
alone and LDL cholesterol levels (p<0.05).  
 
Random blood glucose was related to glycaemic control in univariate analysis          
(p<0.001). However, it was not included in the multivariate analysis because of its 
correlation with glycaemic control. 
 
 
 
 
 
 
  
59 
 
Table 3.8 Univariate analysis of patient factors known in the literature to predict 
glycaemic control 
Risk Factors Crude Odds ratio 
95% Confidence 
Interval) 
P value 
DEMOGRAPHIC CHARACTERISTICS 
Gender                                             
Male                                                                
Female 
 
1                                                      
0.63 (0.36-1.10) 
                                           
0.103 
Race                                        
Black                                                                  
Indian                                                                                     
Coloured                                                  
                                                
1                                                      
0.97 (0.43-2.19)                                       
0.22 (0.03-1.64)       
                                                        
              
0.945                        
0.138 
Age (yrs) 1.01 (0.98-1.03) 0.495         
Employment:                                                                                               
Employed                                                 
Unemployed 
1                                                      
2.54 (1.24-5.19) 
 
            
0.010 
Education:                                   
None                                                                                                                                                  
Some schooling                                                                                    
Completed School  
                                                 
1
1.50 (0.51-4.44)
1.86 (0.53-6.47) 
               
0.464                                   
0.329 
Socio economic classification 0.95 (0.85-1..07) 0.418                              
DISEASE RELATED CHARACTERISTICS 
Time  since diagnosis of diabetes 
(years)                                                      
<5                                                               
5-10                                                            
>10 
 
 
1                                 
0.64(0.33-1.26)            
0.43 (0.22-0.83) 
 
                                  
 
0.198                           
0.012 
Length of time attending the CHC                                                0.98 (0.94-1.03) 0.457 
Type of diabetes treatment (%)                
Combined Therapy                                                               
Injectable                                                        
Oral                                                    
                                                
1                                                      
9.6 (1.18-78.06)                    
15.77 (2.14-116.37) 
                                  
0.034                       
0.007 
Compliance with medication                         
Yes                                                                        
No 
                                              
1                                                     
1.06 (0.56-2.04) 
                                              
0.852 
Received education about diabetes 
at the Clinic                                                                  
No                                                   
Yes 
 
1                                                      
0.96 (0.51-1.81) 
 
                     
0.894 
CLINICAL CHARACTERISTICS   
Blood Pressure                                
Optimal                                                                
Acceptable                                                               
Compromised 
 
1                                                      
1.01 (0.42-2.45)                 
0.78 (0.29-2.05) 
 
                                           
0.983                        
0.609 
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Risk Factors Crude Odds ratio 
95% Confidence 
Interval) 
P value 
Known Hypertensive                                
No                                                                         
Yes 
 
1                                                     
2.0 (0.87-4.60) 
 
                                           
0.102 
 Total Cholesterol (mmol/L) 0.88 (0.69-1.12) 0.295 
HDL-cholesterol (mmol/L) 1.39 (0.67-2.90) 0.373 
LDL cholesterol (mmol/L) 0.74 (0.55-1.0) 0.050 
BMI mean±SD 1.01 (0.97-1.05) 0.455                                       
Random fingerprick Glucose 
(mmol/l)              
  
 0.72 (0.64-0.80) 
 
0.000 
BEHAVIOURAL FACTORS   
Alcohol Consumption                                
No                                                                   
Yes                                                                         
                                               
1                                                      
1.46 (0.79-2.71) 
                                            
0.229
Physical Activity                                       
Low                                                                
Medium                                                               
High 
 
1                                                      
1.73 (0.86-3.49)                 
1.06 (0.44-2.55) 
 
                                           
0.125                        
0.900 
 
Of the 19 potential factors selected from the review of literature, four variables 
(employment, time since diagnosis LDL cholesterol levels and type of diabetes 
treatment), using univariate regression, were significantly associated with the 
outcome (Table 3.8). Using automatic variable selection, six variables (gender, race, 
type of diabetes treatment, physical activity levels, employment and levels of 
education attained) were found to be significantly associated with good glycaemic 
control. Two variables (employment and type of diabetes treatment) were common to 
both of these selection approaches.  
 
Variables included in the final model are shown in Table 3.9. Gender, type of 
diabetes treatment, time since diagnosis of diabetes and employment were all 
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significantly associated with good glycaemic control (p<0.05). The inclusion of the 
variable race, although marginally significant, into the model gave a final model that 
had the best overall fit. Females were less likely than men to have good glycaemic 
control while Coloureds had poorer glycaemic control than Black. Patients who used 
oral or injectable treatment had better control than those who used combined 
therapy. Unemployment was associated with better glycaemic control with 
unemployed patient about 4 times more likely to have better control than employed 
patients. 
The final model had a good fit (p= 0.36) and the area under the ROC of 0.74 was 
good, implying this model could well predict good glycaemic control for this study 
population.  
Table 3.9 Multivariate analysis of patient factors known in the literature to predict 
glycaemic control 
Risk Factors Adjusted Odds ratio 
(95% Confidence 
Interval) 
P value 
Gender n (%)                                      
Male                                                                
Female 
                                                  
1                                                            
0.49 (0.26-0.92) 
                                     
0.026 
Type of diabetes treatment (%) 
Combined Therapy                                                               
Injectable                                                        
Oral                                                   
                                                  
1                                                            
11.06 (1.34-91.30)                             
15.44 (2.07-115.46) 
                                                     
0.022                                                        
0.012 
Time  since diagnosis of diabetes 
(years)                                               
<5                                                         
5-10                                                         
>10 
                                                      
 
1                                                 
0.68 (0.33-1.40)                                  
0.49 (0.24-1.01)  
          
                      
0.293                                 
0.052                                     
Race n (%)                                                     
Black                                                                
Coloured                                                     
Indian                                              
                                                 
1                                                 
0.14 (0.02-1.16)                               
0.92 (.036-2.34) 
                                                   
0.060                                                        
0.849 
Employment                                                 
Yes                                                         
No 
                                                 
1                                                 
3.65 (1.67-8.01) 
                                 
0.001 
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3.5 Health facility related factors 
3.5.1 Facility description 
All three of the CHCs have dedicated days and clinics for diabetes care.  
 
 Chiawelo CHC 
Chiawelo CHC serves a predominantly Black African population. There is no booking 
system for appointments and all patients arrive at once. Chris Hani Baragwanath 
Hospital is the referral hospital for Chiawelo CHC and is in very close proximity to the 
CHC (about 9km). There is a committee for quality assurance at this CHC and they 
meet monthly to discuss issues at the CHC generally. Medicine is dispensed on site 
from the pharmacy. There has not been an interruption of medicine stock at this 
CHC in the one year prior to this study being conducted.  
 
 Discoverers 
Discoverers CHC has a dedicated diabetic clinic with a semi structured method of 
appointments. Patients are advised to arrive at intervals. Helen Joseph Hospital is 
the referral hospital and is approximately 7 kilometres away. There is no system in 
place for detecting or tracing defaulting patients as it is felt that many patients at this 
clinic give false addresses. There has been no interruption in the medication stock 
supply in the past year prior to this study.  
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 Lenasia South CHC 
Lenasia South CHC refers diabetes patients with complications to Chris Hani 
Baragwanath Hospital which is 45 kilometres away. There is no booking system that 
allows the staggered arrival of patients. There are no systems in place for tracing 
defaulting patients. Quality of care gets discussed in the general primary health care 
nurses meetings, but no forum exists to discuss diabetic patient management 
specifically. Medicines are dispensed directly from the CHCs pharmacy. In the six 
months prior to this study, the supply of Metformin ran out once. Stock was borrowed 
from another CHC, Lillian Ngoyi CHC in Soweto.  
 
Table 3.10 below describes the patient load of the CHCs in the six month period 
prior to this study. The table also highlights the staff complement at each CHC. 
 
None of the clinics had access to a chiropodist and only one clinic (Discoverers CHC) 
had a registered dietician.  From the total number of patients seen in the six month 
period it appears that all three CHCs have a similar number of doctors and 
professional nurses despite different patient loads. Although Lenasia South CHC has 
far fewer patients, they have more new diabetic patients than Chiawelo CHC and a 
higher number of visits for diabetes than Discoverers CHC. 
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Table 3.10 Staff complement and patient load at the three CHCs for the six month period, May-
Oct 2008 
 Chiawelo CHC Discoverers 
CHC 
Lenasia South 
CHC 
Total number of patients (facility count) 93031 89028 36114 
Total number of patients seen at the 
chronic diseases clinics 
39247 38407 15671 
Total number of new diabetics 15 51 35 
Total number of diabetic follow up visits 5964 4006 4566 
Average number of overall patients seen 
per month 
15 505 14 838 6019 
Total number of doctors  4 4 4 
Ratio of doctor: patient per month                       
( NOT diabetes specific) 
1: 3976 1:3709 1:1504 
Number of dieticians at the CHC 0 1 0 
Professional nurses   
Staff nurses 
Nursing assistants                                 
43 
16 
12 
42 
7 
18 
40 
15 
9 
Health promoters  3 4 1 
 
   
3.5.2 Access to CHCs 
A high percentage, 88.9% (n=394), of the participants were noted to be attending 
their nearest primary health care clinic. The highest proportion of patients attending 
at a facility that was not considered their closest health facility was at Discoverers 
CHC (26.1%). There was no significant difference in glycaemic control between 
those who attended their nearest clinic and those who did not (p=0.219). 
Whilst 30% of the study population walked to the CHC, the majority (38.6%) used a 
taxi. Twenty three percent % travelled by car and the remainder used a combination 
of train (7.4%) or bus (0.7%).  
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An overwhelming proportion of participants found that staff at all the CHCs was 
friendly and helpful and a high proportion were generally satisfied with the care they 
received at these CHCs for diabetes (Table 3.11).  
 
Table 3.11 Patient perception of staff and overall services at the three CHCs 
 Chiawelo 
CHC 
(n=204) 
Discoverers 
CHC (n=90) 
Lenasia South 
CHC (n=100) 
Complete sample: 
all clinics (n=394) 
% Attending their 
nearest clinic 
97.4 73.9 85.7 88.9 
Perception of staff (%):                 
Friendly                                            
Helpful           
                                    
95.6                         
93.6                          
                                            
98.9                                      
98.9 
                                          
91                                      
94 
                                        
95.2                               
94.9              
 
% satisfied with overall 
clinic care 
 
90.69 
 
100 
 
88.89 
 
92.4 
 
3.5.3 Equipment 
Table 3.12 below highlights the equipment available at the CHCs for diabetes care. 
Chiawelo CHC appears to have a shortage of equipment despite having the busiest 
diabetic clinic.  
       Table 3.12  Functional equipment available at the three CHCs for the diabetic clinics 
 Chiawelo  
CHC 
Discoverers         
CHC 
Lenasia South 
CHC 
Weighing scales(n) 2 * 2 1 
Glucometers 1# 7 2 
Sphygmanometers 3* 7 5 
ECG machines 0 0 0 
Snellens charts 1 0 4 
Height scale 0 2 1 
Fundoscopes 0 0 4 
Tape measure (for waist measurement) 0 1 0 
                    *One of each of these was NOT in working order    
            # Although only one exists; there have been times when this has NOT been in working order 
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Healthcare staff indicated that some patients were able to purchase their own 
glucometers for self monitoring of their blood glucose levels, but the CHCs were 
unable to supply the glucose sticks required for testing. 
 
3.6 Healthcare professional related factors 
 
3.6.1 Healthcare Professional interview findings 
Fourteen healthcare professionals, 11 nurses and 3 doctors, were interviewed. The 
average number of years of experience was 20 years (SD: 9.3) and ranged from 4 
years to 36 years. Most respondents were women (93%). The median time working 
at the CHC being studied was 9 years, ranging from 5 to 24 years.  
 
Capacity to manage diabetes 
Only one healthcare professional was not aware that National Guidelines for 
Diabetes Management existed. Almost a third (29%) admitted to not strictly adhering 
to these guidelines. Four of the healthcare staff interviewed did not have a copy of 
the guidelines or know where to access a copy.  
 
As an example of guideline adherence, Table 3.13 below indicates the blood glucose 
values used by healthcare professionals when diagnosing diabetes.   
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Table 3.13 Target values used by healthcare professionals to diagnose diabetes in 
symptomatic individuals 
Upper limit of random blood sugar level used to diagnose diabetes 
in symptomatic patients (mmol/l) 
N (%) 
7 2 (14.3) 
9 2 (14.3) 
10 1 (7.1) 
11 3 (21.4) 
15 5 (35.7) 
17 1 (7.1) 
 
Three health care professionals did not provide any answer at all as to the upper 
limits of normal of the HbA1c test. A further three healthcare professionals chose 6% 
as the upper limit of normal, four others chose 7%, two chose 8% and one 
healthcare professional chose 10%. When asked how often the HbA1c test should be 
done, 42% indicated six monthly and 33% said yearly. One responded that the 
HbA1c test should be done whenever a patient is found to have poorly controlled 
random blood sugar levels. Two offered no response at all to how often the HbA1c 
should be conducted and lastly one respondent indicated that testing should be 
conducted every three months.  
 
Thirty six percent of healthcare professionals agreed that glucosuria can be used as 
a diagnostic tool for diabetes and that a fasting glucose tolerance test would be 
deemed unnecessary if glucose was present in the urine.  
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Healthcare professionals were asked to comment on whether they were comfortable 
performing the following tests. The percentages reflected in Table 3.14 indicate the 
proportion of those that were comfortable performing the test.  
 
Table 3.14 Proportion of healthcare staff comfortable performing diabetes care related 
procedures/tests 
               Test % comfortable n=14 
1. Visual acuity 12 (86%) 
2. Fundoscopy 1 (7%) 
3. Urine dipstix 14 (100%) 
4. Complete foot exam 9 (64%) 
5. Neurological exam for nerve damage 2 (14%)  
 
The consensus (12/14) was that the quality of care provided is considered better in 
dedicated diabetic clinics versus general chronic disease clinics and general primary 
care clinics.  
Patient workload 
Nurses stated that they saw on average approximately 30-40 patients during each 
diabetic clinic. Staff at Chiawelo clinic however indicated that they saw between 80-
120 patients as a norm during each diabetic clinic.  
 
3.6.2 Patient Education 
The majority of patients reported receiving education about diet, exercise and 
footcare from either a doctor or a nurse whilst being managed at the respective 
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CHCs (Table 3.15). Approximately 76% of the patients indicated that they had 
received general information about diabetes. 
 
Of those who were well controlled; 75% (n=62) indicated that they had received 
diabetes education and 25% had not. Of those poorly controlled 76% (n=332) 
indicated they had received education. There was no difference between those with 
good glycaemic control and those with poor control, in terms of the reported diabetes 
education received (p=0.894).  
 
Table 3.15 Indication of education received at the CHCs 
 Chiawelo CHC 
(n=204) 
Discoverers 
CHC (n=90) 
Lenasia South 
CHC (n=100) 
Total sample 
(n=394) 
P value 
Reported diabetes 
education received 
.      General diabetes 
education                                     
Diet education                             
Exercise education                  
Footcare education  
 
 
 
144 (70.6)                      
155 (76.0)             
151 (74.0)                        
122 (60.4) 
 
 
 
78 (86.7)                            
86 (86.9)                               
78 (86.7)                            
75 (83.3) 
 
 
 
77 (77.8)                             
86 (86.7)                       
84 (84)                                 
75 (75) 
 
 
 
299 (76.1)                 
319 (81.2)                      
313 (79.4)                            
272 (69.2)    
 
              
 
 
0.011
 
3.6.3 Challenges to providing comprehensive care 
Healthcare professionals interviewed highlighted a number of challenges they faced 
in providing adequate diabetic care-:  
 Most believe that 15-20 minutes is the minimal required consultation time per 
patient if adequate care is to be provided. Due to current staff shortages, it is 
not possible to dedicate this amount of time.   
 Necessary patient measurements are not always done:  
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a) Nursing assistants employed to assist at the clinics with routine 
measurements are often reluctant to conduct urine tests and weigh 
patients when patient volumes are high.   
b) Lack of working equipment was often an obstacle to staff that are required 
to conduct routine measurements, including weight measurements and 
random fingerprick glucose measurements Glucometers, weight scales and 
height scales were in short supply (refer Table 3.12 for working equipment). 
 Health promotion talks are supposed to be given during the clinics and this is 
not always done due to insufficient support staff.  
 Health talks are sometimes given in a language that does not benefit all 
patients present. For example in diverse population groups like those at 
Lenasia South Clinic, patients have a variety of home languages. Talks are 
often given in one chosen ethnic language and many of the English speaking 
patients do not comprehend.  
 Dieticians are not available during the clinic times. There is no avenue to refer 
patients who required a dietician consult. Only 3% of participants had ever 
been counselled by a dietician.  
 Diabetic diaries were not always available and teaching materials were 
inadequate. The numbers of diabetic diaries supplied by the Department of 
Health were never enough. 
 Lipid lowering drugs were unavailable at the three CHCs studied. Patients 
need to be referred to secondary and tertiary institutes and opt to avoid this 
scenario due to perceived long waiting times at these facilities 
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 Most CHCs have a poor booking system whereby all patients to be seen for 
the day arrive all at once, usually in the mornings. Patients get impatient with 
the prolonged waiting times and are content with a rushed consultation so that 
they can get home sooner.  
 Blood test results are often unavailable. This is usually due to a poor system 
of attaining blood results or organisation of results. As a result both patients 
and staff do not put much emphasis on taking blood tests. Only a small 
percentage of the participants (16%) have had an HbA1c test done previously. 
Of those classified with poor glycaemic control, only 5.7% (n=332) had 
records of previous total cholesterol testing being conducted in the past one 
year. 10.2% (n=332) were noted to have compromised total cholesterol levels 
from blood testing conducted as part of this study with just 2.52% of 
participants noted to be on lipid lowering medication.  
 Not enough attention is dedicated to encouraging patient compliance. There is 
a tendency for the nurses to increase the dosage if insulin when in fact 
lifestyle modification or importance of medication compliance deserves more 
attention. 
  
72 
 
CHAPTER FOUR  
4.0 DISCUSSION  
 
4.1 Discussion 
In this chapter, the results obtained from the analysis of the study data are discussed 
and interpreted in light of other published studies. 
 
This study showed that patients who had diabetes for a shorter period of time, used 
oral therapy alone or injectable therapy alone, who were male, and those 
unemployed, were more likely to have good glycaemic control. In terms of race being 
Coloured had the least likely odds of being well controlled as compared to being 
Indian or Black African.  
 
The aim of this study was to determine factors that influence glycaemic control in 
patients at selected community health centres in Johannesburg. Factors that 
influence glycaemic control are vast and difficult to investigate extensively in one 
study, thus factors that were mainly considered to be modifiable in the Gauteng 
context were included in this study. This study focused on demographic features, 
disease severity, clinical characteristics, access/quality of care, and behavioural 
factors. Studies do suggest that personal characteristics of patients alone may not 
explain the reasons for glycaemic control among patients with type 2 diabetes.83-84 
This study did not attempt to explore psychological, some biological factors or the 
self care skills needed for good glycaemic control.  
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Diabetes is not only a problem in the developed world; it has become an increasing 
health problem in less developed countries as well. By 2015, it is estimated that in 
Africa mortality from non-communicable diseases will exceed that from 
communicable diseases.63  
 
4.1.1 Glycaemic Control  
Good glycaemic control was only described in 15.7% of the study population. This 
proportion was slightly lower than other studies that have investigated / measured 
glycaemic control in South Africa. In a study carried out in a rural district in KwaZulu-
Natal, acceptable glycaemic control (defined as HbA1c< 2% above normal population 
range) was found in only 16% of patients.34 Similarly a study looking at patients 
attending a  peri-urban community clinic with predominantly black patients, found 
that good glycaemic control (HbA1c < 7%) was achieved in only 20% of patients.35 In 
Black African patients at the primary care level in the public sector in the Western 
Cape, acceptable glycaemic control (defined as HbA1c < 2% above normal 
population range) was found in 49% of patients.31 Studies from other countries also 
showed poor levels of glycaemic control. A study in Jordan estimated that the 
proportion of Type 2 diabetic patients who did not achieve good glycaemic control 
was 65.1%.85 In Kuwait, 66.7% of the studied population had an HbA1c ≥8%.86 In 
Trinidad 85% of patients had HbA1c >7%87 and in the UK, 69% had HbA1c >7.5%.88 
Glycaemic control appears to be a worldwide problem. 
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4.1.2 Patient related factors influencing glycaemic control  
 
Gender   
More women (70%) than men participated in this study. This might be that more men 
were in employment and thus unable to attend at primary health care facilities during 
working hours.  The high proportion of women in the study population is comparable 
to previous studies on glycaemic control in SA,12,15,89 showing that the gender of 
patients attending primary care facilities for chronic disease care in South Africa is 
predominantly female.   
 
This study found that diabetic women were less likely, when compared to men, to 
have good glycaemic control. A study looking at type 1 diabetic patients, suggested 
that a possible reason that women may have poorer glycaemic control is that women 
have reported greater difficulty in adhering to the diabetes regimen than men.90 
Wexler et al10 showed that diabetic women were also noted to be less likely to have 
well controlled blood pressures or LDL-cholesterol levels compared to men. Clarity is 
required in understanding the reason that women are less likely to be well controlled.  
 
Previous South African studies have also re-enforced the findings of a high 
prevalence of obesity, (BMI≥25 kg/m2 for females and BMI≥27 kg/m2 for males) 
which was present in 79% of diabetic patients in one study.35 The prevalence of 
obesity (BMI >30 kg/m2) in South Africa is high, with more than 29% of men and 56% 
of women being classified as overweight or obese.91 Increasing levels of obesity and 
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insulin resistance has been associated with poorer glycaemic control.61-62 Perhaps 
the fact that women in South Africa are more obese than men contributes to their 
poorer glycaemic control and warrants further investigation.  
 
Being overweight had no significant association with glycaemic control in this 
particular study, and findings were similar to another international cross-sectional 
study in primary care.92 The United Kingdom Prospective Diabetes Study (UKPDS 
trial)18 has explained that good glycaemic control can cause weight gain of between 
2 and 5kg.18 However this may not be relevant to this study population in light of the 
already high mean BMI of 31.3kg/m2. The adverse effect of weight gain on glycaemic 
control may worsen other physiological parameters such as hypertension and 
hypercholesterolemia, which are important risk factors for cardiovascular disease.93  
 
Employment 
Employment was found to be a significant predictor of glycaemic control in our 
multivariate model with unemployed people having a higher probability of being well 
controlled than those in employment.  It may be that patients with employment have 
less time for clinic attendance or self care. There is little supporting literature for this 
association between unemployment and better glycaemic control. This finding 
contradicts a theory highlighted by Wray et al57 that better education levels result in 
better occupational prospects and higher incomes, which would result in improved 
health outcomes through safer and less stressful workplaces, greater access to 
health literacy and information as well as better social networking.   
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Length of time since diagnosis of diabetes 
Although no studies have formally been conducted in SA on the effects of length of 
time of diabetes and glycaemic control, international study findings have differed on 
the association between glycaemic control and disease duration.31,84,92 This study  
found that the longer the duration of diabetes the harder it was to maintain glycaemic 
control. These findings were similar to Blaum et al92 and contradictory to Nichols et 
al.84 In 1997 Curtin et al94 reported that conformity to medical care improved with 
age. Although this improvement was expected with longer duration of disease, 
resistance to medication and the need for higher doses or additional medications 
also increased over time.95-96 Longer duration of diabetes is often associated with 
poor control, possibly because of progressive impairment of insulin secretion with 
time due to β-cell failure, which makes the response to diet alone or oral agents 
insufficient.18 
 
Type of treatment 
Participants in this study on oral medication alone or injectable therapy alone were 
found to have much greater odds of having good glycaemic control than patients on 
combination therapy. The association between treatment with a combination of oral 
and injectable medication and poor glycaemic control is consistent with other 
studies.85,97-98 Insulin, which is used as a first line of therapy in type 1 diabetics is 
also recommended in addition to oral medication as second or third-line therapy, 
when glycaemic targets in type 2 diabetes mellitus are unmet.27 The  use of insulin 
often reflects disease severity and some studies83,95-96 have used it as a predictor of 
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poorer glycaemic control. Only 17.6% of this study population were on injectable 
therapy alone, of which 89% were poorly controlled. Diabetes does deteriorate over 
time and perhaps those on combination therapy in our study population had a more 
progressive form of the disease which required more aggressive second and third 
line therapy.  
 
Race  
A prior study has demonstrated race/ethnicity as a predictor of glycaemic control 
showing higher proportions of poorly controlled patients among black women and 
Mexican-American men.95 Utilising multivariate analysis, this study found that 
patients of Coloured race were least likely to have good glycaemic control when 
compared to Black African and Indian race groups. This finding of patients from the 
Coloured race being least likely to be well controlled, is in keeping with the South 
African Institute for Race Relations' “South Africa Survey 2008/9”,99 which reported 
that people who were Coloured were most likely to have had diabetes as one of their 
three leading causes of death. The white race was poorly represented in this study 
sample with only three participants noted overall and they were therefore not 
included in the multivariate analysis.  
 
Urbanisation is a major risk factor for the development of chronic diseases100 and as 
populations migrate from rural to urban areas in South Africa the proportion of race 
groups affected by chronic diseases may change.  
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Socio-economic status 
Although it is known that the distribution of non-communicable diseases has 
disparities in terms of socio-economic status100-101 this study found no association 
between an asset indicator score, utilised to reflect socio-economic status, and 
glycaemic control. There was also no difference between the means of the asset 
indicator scores for those with good and poor glycaemic control. These findings, 
were similar to a US study by Harris et al,83 the Michigan community study,92 Benoit 
et al95 and a study of blacks and whites in South Carolina,102 with all finding no 
association between glycaemic control and socioeconomic status. One study 
however in the USA found that patients from higher socioeconomic levels were more 
likely to achieve better glycaemic control.16 It should be noted that although the asset 
indicator score used in this study was adapted from an asset indicator score used in 
other studies to asses socio-economic status, this adapted score was not validated 
in this study population.  
 
Age 
Similar to a study by Benoit et al,95 age was also found not to be a significant 
predictor of glycaemic control in this study. Some previous studies have reported 
that younger aged diabetics are more likely to be poorly controlled.42,84 Early-onset 
type 2 diabetes is generally more associated with poorer glycaemic control 
outcome,42 and possibilities for this outcome include behavioural reasons and the 
suggestion that glycaemic control may be much more difficult to achieve for some 
younger patients with a shorter duration of disease.84 Currently there are no known 
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studies that have evaluated whether individuals developing type 2 diabetes at an 
earlier age require more aggressive interventions to achieve glycaemic control. 
 
Co-morbid conditions 
Blood pressure measurements conducted during this study revealed that 20.5% of 
patients had blood pressures that were considered to be in the compromised 
category according to the NDoH guideline. In this study 80.8% of the population 
reported that they were known hypertensives and this high proportion may have 
contributed to the lack of finding a significant relation between being hypertensive 
and glycaemic control. Previous studies in South Africa have shown that poorly 
controlled diabetics are also often found to be hypertensive and obese,38,40 with up to 
76% of black diabetic women having coexisting hypertension and being obese in one 
study.40 Having a multitude of diseases can often lead to or enhance difficulties in 
treatment compliance and lifestyle modification. Persons with co-morbid chronic 
diseases experience a wide range of barriers to self-care, often leading to poor 
overall control.53,68 So whilst the existence of a co-morbid factor may not directly 
predict glycaemic control, it may influence areas of compliance and lifestyle 
modification.  
 
Diabetes and hypertension are not only increasing in urban African settings but in 
rural settings as well. Harris et al83 found that blood pressure was elevated (greater 
than or equal to 140/90mm Hg) in 55% to 65% of the diabetic population. A SA study 
found hypertension (blood pressure ≥ 160/95mmHg and/or prescribed anti-
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hypertensive medication) was present in 65% of patients, and severe obesity (BMI > 
33 kg/m2) in 37% of patients34 with poorly controlled diabetes. Levitt et al31 found a 
high prevalence of suboptimal glycaemic and blood pressure control with 
hypertension (blood pressure ≥160/95mmHg and/or prescribed antihypertensive 
medication) present in 52% of diabetic patients.31 
 
Benoit et al,95 found in their study that high total cholesterol was associated with 
poorer glycaemic control. In another study it was also found that the total cholesterol       
was greater than or equal to 200 mg/dl in 62% to 69% of the diabetic              
patients investigated.83 Diabetic patients are already at high risk for cardiovascular 
disease, thus elevated cholesterol levels need to be treated. Despite this known fact, 
only 2.5% of this study population were on lipid lowering drugs, whilst 10.2% were 
noted to have elevated total cholesterol levels. Although hypercholesterolaemia 
should be routinely screened for in diabetics, according to NDoH diabetes 
guidelines, only 5.3% of this study sample has previously had their total cholesterol 
levels tested. The use of lipid lowering drugs is recommended in the national 
guidelines, however due to limited resources, the implementation of this therapy is 
very low.        
                                 
Behavioural / lifestyle factors influencing glycaemic control  
A study on dietary intake and barriers to dietary compliance in Black African type 2 
diabetic patients suggests that healthcare professionals be re-trained in concepts of 
optimal diabetic diet which is culturally and economically acceptable to Black African 
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patients.38 Factors that were identified as possible contributors to poor glycaemic 
control from this study included: lack of knowledge regarding the disease; 
inadequate and inaccurate dietary counselling; and poor compliance with the dietary 
advice given. This study was only able to determine the number of days in a week 
that diabetic patients from the study ate fresh fruit and vegetables, as it was never an 
intention to extensively investigate dietary habits of the study population.  
 
The highest proportion of patients at all three CHCs were classified as undertaking 
moderate physical activity. Although previous studies64-65 have shown that improved 
physical activity levels can result in better glycaemic control, no significant 
association with glycaemic control was found in this study, either on univariate or 
multivariate analysis.  
  
Compliance 
Surprisingly compliance was not found to be a significant predictor of glycaemic 
control in this study. One study found that poor glycaemic control was more common 
among patients who were not adherent to their treatment.87 There is some difficulty 
in assessing patient compliance to diabetic medication and diabetic lifestyle 
modification. The nature of the question phrased in this study questionnaire, i.e. a 
closed question, may have left patients with the tendency to say “yes” when asked 
about their compliance to diabetes medication or perhaps they gave false 
information in fear of reprimand. Often many patients are found to be on injectable 
therapy due to poor compliance rather than a failure of oral medication. 
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4.1.3 Health facility related factors influencing glycaemic control 
A key strength in interviewing health care professionals and facility managers is that 
these personnel are responsible for delivering care and thus allows for a more 
personalised insight into the delivery of services and the difficulties experienced with 
delivering good quality care.  
 
Previous international studies have indicated that smaller clinics achieve better 
glycaemic control and might be influenced by better interpersonal skills related to 
lower workloads.16 Contrary to this, it was found in this study, despite the fact that all 
three CHCs had dedicated diabetes clinics, patients attending the clinic with the 
higher number of diabetics seen, displayed a higher proportion of glycaemic control. 
 
Although the mean HbA1c level was similar for all three CHCs, the proportion of 
patients who achieved good glycaemic control was significantly different. The CHC 
with the highest proportion of good glycaemic control had the highest patient volume, 
a predominantly black population, the oldest average age of patients, the highest 
proportion of patients that were employed, the lowest proportion of patients who 
were diabetic for more than 10 years and the highest proportion of patients on oral 
therapy alone. Except for these predominantly patient characteristics, this study did 
not identify any key organisational findings that differentiated this clinic from the 
other two. Thus an overall effort to improve diabetes care at all clinics is logical from 
a management perspective. The study did not allow for a comparison between 
patient, health professional and facility factors.  
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Patients expressed some concerns in terms of facility management. The main 
frustration was the poor flow of patients through the clinic. All patients with 
appointments for clinic attendance on that particular day were expected to arrive at 
the same time, early in the morning. In view of it being impossible to see all these 
patients on arrival, the majority of patients spent many hours waiting in queues. 
Patients are often disillusioned with the long waiting times and accept rushed 
consultations as a norm. Annual physical examinations are not routine in health 
facilities, and the public are not well informed about the need for routine physical 
examination to detect disease early and initiate appropriate care.103 
 
A study has shown that the existence of defaulter detection systems can be 
associated with overall improved glycaemic control.25 All three CHCs lacked a 
system to detect defaulters.  
 
Although the study concludes that patient related factors are at the forefront, 
improved strategies in all spheres, including facility management can also improve 
the level of glycaemic control in patients attending the CHCs.  
 
4.1.4 Health care professional factors influencing glycaemic control  
The health care professional can play an important role in achieving good glycaemic 
control. Characteristics such as good communication skills, enthusiasm and care 
may determine whether a health care professional will influence glycaemic control 
but these cannot be easily measured as these characteristics are difficult to test for. 
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Other studies have shown that healthcare professionals have minimal direct impact 
on glycaemic control,104-106 but that these professionals do influence patient 
behaviour and thus diabetes outcomes.  
 
Healthcare professionals reported that they did not feel they are adequately trained 
in diabetes care. This could be a possible reason why healthcare professionals were 
not comfortable performing certain essential diabetes related examinations as well 
their lack of knowledge when asked simple basic diabetes related questions. A 
previous South African study by Levitt et al36 highlighted the limited training of health 
personnel in a comprehensive approach to chronic diseases stating that both 
medical and nursing curricula in 2005 focused on curative care, rather than a 
comprehensive approach that incorporates prevention, promotive and rehabilitative 
aspects. The skill to manage chronic diseases was lacking in many health care 
workers. A European study in primary care which looked at 288 poorly controlled 
diabetic patients, found that after supporting health professionals with flow-charts 
and treatment protocols, a 17% reduction in HbA1c levels was noted, suggesting an 
element of under-performance prior to this intervention.97 
 
Despite the existence of national guidelines for the management of diabetes in South 
Africa, the implementation of these guidelines appears to be poor in view of the low 
proportion of patients who have previously had their HbA1c levels tested, the low 
proportion of patients who have had examinations specific to identifying diabetes 
complications; the low proportion of patients that have been referred for specialist 
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care, e.g. dieticians, ophthalmologists;  as well as a very low proportion of patients 
that were found to have good glycaemic control. It appears that healthcare 
professionals are not adhering to protocols. 
 
Good glycaemic control does depend on diabetes education that patients receive 
from health care professionals.37 In this study patient perceptions about the diabetes 
education that they received did not feature as a predictor of glycaemic control. A 
high percentage of diabetic patients indicated that they were satisfied with the care 
as well as the education about diabetes received at the CHCs. This overwhelming 
positive response might be attributable to the nature of the question asked, i.e. 
closed questions. The scope of this study did not accommodate for determining the 
actual extent or quality of patient education given by healthcare professionals as the 
questions asked were not sufficient  to know exactly how much knowledge patients 
had about their disease, how much information they received and from whom. In 
considering the amount or quality of education that diabetic patients receive, it is 
important to be cognisant of the high patient volume and the fact that any one nurse 
can see up to 90 diabetic patients within a working day. This high patient to staff ratio 
is a potential contributor to poor glycaemic control as it may limit the time available 
for quality patient education.  
 
A moderate inverse relationship was observed between educational level and 
glycaemic control. In this population almost 86.5% of the patients had not completed 
formal schooling. Diabetes is a ‘complex’ disease; as such providers of diabetes care 
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need to be aware of the potential influence of educational level on the patients’ 
receptiveness to the education and information made available to them. Authors 
have emphasised the significance of health literacy in diabetes care.50,107 In 
particular it is recognised that diabetes information needs to be adjusted to a 
patient’s literacy levels, cultural beliefs, environment influences and economic 
status.38,50,108  Health literacy is a measure of a patient’s ability to read, comprehend 
and act on medical instructions. Poor health literacy is common among patients who 
have achieved lower levels of educational attainment and among patients with 
chronic medical conditions, such as type 2 diabetes.108 
 
This study found that the random blood glucose measurement appeared to be 
associated with glycaemic control. This association of high random blood glucose 
with poor glycaemic control may highlight the usefulness of this simple and cheap 
test which can be utilised by primary care clinics in daily diabetes care. Following 
persistently high random glucose readings, a patient should have an HbA1c test. This 
study highlighted that only 16% of the study population had ever had an HbA1c test 
according to their patient records. Although random blood glucose testing may be 
useful in the primary care setting, a caution of relying solely on random blood 
glucose measurement comes from a study by Bouma et al109 in non-insulin-using 
patients, which highlighted a risk for under-treatment in view of the overestimation of 
HbA1c from good fasting plasma glucose levels (<7.8 mmol/l) especially in patients  
on oral diabetic therapy.109 Although random blood glucose should be tested at all 
clinic visits, healthcare professionals do not appear to be using this test as an 
  
87 
 
indicator that a patient may be poorly controlled and require further investigation with 
an HBA1C test. 
 
4.2 Limitations 
The findings of this study must be interpreted taking into cognisance the limitations 
of the study. The factors identified in the literature review were investigated in this 
study as independent variables only.  
 
Due to the cross-sectional design of the study, temporality between the factors 
influencing glycaemic control could not be assessed and therefore causality could 
not be measured. 
 
It is possible that some variables, for example self-reported alcohol use and 
compliance to treatment, may have suffered from social desirability bias as patients 
may consider some practice socially sanctioned. It would be interesting to investigate 
the validity of these measures in a future study. The usefulness of these measures is 
also limited due to the closed nature of the questions asked.  
 
The size of this study population was adequate, but the diversity of the population 
both in terms of race and socioeconomic status were not fully represented. In South 
Africa higher socio-economic groups usually seek healthcare within the private 
sector. Only three participants were white, and a high proportion of patients were 
unemployed. On multivariate analysis those unemployed were more likely to be well 
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controlled. The possibility that the study sample had an element of selection bias, in 
that more people who were unemployed were selected, cannot be ruled out. This 
bias would be due to the fact that more people who are unemployed tend to use 
health services at the selected CHCs.  
 
Some patients sampled did not wait for the study interview perhaps for reasons of 
time constraints, other commitments such as being in employment or scepticism. We 
were unable to determine the number of people who did not wait around for an 
interview. Those who left may have less interest in the control of their diabetes; may 
have been men and perhaps were worse controlled. Potentially these same patients 
could have been from a better socio-economic background and thus perhaps had 
better glycaemic control.  
 
Health professional and health facility factors that may influence glycaemic control 
could not be entered into the logistic regression model due to lack of variation as well 
as difficulty in assigning the responses of individual health care providers to specific 
patients.  
 
4.3 Conclusion 
The majority of patients in this study had poor glycaemic control. The determinants 
of the quality of glycaemic control and diabetes care are multiple and complex with 
inputs and interactions at the patient, health care provider and the health facility 
level. 
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Several patient characteristics were found to be associated with good glycaemic 
control. Patients with a shorter duration of diabetes, those who were male Black 
African, unemployed and treated with oral medication alone were more likely to have 
good glycaemic control.  
 
Healthcare professionals self reported that some of their diabetes management skills 
were lacking. This study showed there were health professionals who were unable to 
answer simple questions related to the management of diabetes which may be 
related to the training of healthcare professionals in the area of chronic disease 
management, suggesting a need to improve health professional diabetes education. 
 
There appears to be poor adherence to NDoH diabetes guidelines, as evidenced by 
the vast majority of patients having never had an HbA1c test. Several challenges to 
providing comprehensive care were reported by healthcare professionals, including 
high volumes of patients encountered with minimal consultation time to ensure 
quality of care, lack of working equipment, no access to dieticians during clinic times, 
shortage of diabetic diaries and difficulties in obtaining blood test results. Some of 
the challenges reported suggest that there is a need to improve the management of 
the healthcare facilities.  
 
Addressing these findings with a comprehensive plan of action is needed to help 
reduce the increasing epidemic of diabetes and its complications among diabetic 
patients in the JMHD. 
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4.4 Recommendations  
There is a definite need to improve glycaemic control in the Gauteng province. The 
findings of this study will contribute to the strategic plans of the GDoH in addressing 
the growing diabetes epidemic in the province by ensuring that the:  
 Current clinical management guidelines be adapted such that people who 
have been diabetic for longer periods of time be targeted for intensive management. 
These patients must undergo closer monitoring (regular recommended HbA1c 
testing, higher vigilance for the possibility of complications),  have more detailed 
healthcare professional consultations, be referred timeously if and when 
complications arise, and healthcare professionals must have a lower threshold for 
increasing therapy with these patients.  
 Current guidelines and policies be reinforced, such that all diabetic patients 
receive at least one annual physical examination as well as six monthly HbA1c blood 
tests.  
 There is a growing need for monitoring and evaluation of the implementation 
of current policies and guidelines. A potential value add to assist in the monitoring 
and evaluation process is the conducting of more regular clinical audits at facilities, 
scrutinising patient records to identify inconsistencies with current guideline 
adherence and ensuring that essential management practices like diabetic foot care, 
dietary advice and six monthly HbA1c testing are being conducted as prescribed.  
 Further implementation of mechanisms, programmes and processes that 
assist health staff attain confidence in terms of the referral pathways and in 
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becoming more vigilant of potential diabetic complications are critical in enhancing 
better glycaemic control. 
 
The primary health care professional plays a pivotal role in the patient’s chances of 
achieving good glycaemic control. It is this important role that necessitates prudent 
investment in the continuous education and training of the health care professional to 
enable them to optimally ensure the glycaemic control of their diabetic patients. 
Many health care professionals interviewed in this study expressed interest in a 
refresher course which could improve the quality of care provided to diabetics at the 
primary care level and reduce the number of referrals to the secondary and tertiary 
level with long and short term complications of diabetes. Experts in the field of 
diabetes must be approached in helping refresh the nursing staffs’ knowledge and 
practices regarding diabetic patients. This could have a very positive impact on the 
lives of many diabetics in the Johannesburg region.  
 
The health facilities should aim to ensure that all patients under their care are 
empowered to practice self management, are educated about the importance of 
compliance and are well motivated. Patients should be well educated with regards to 
the possible risk factors associated with poor glycaemic control and how to control 
them as well as possible complications and how to identify them. The promotion of 
self care is vital in sustaining good glycaemic control. Dieticians and nursing staff 
specialising in this field of study would contribute immensely in cultivating an 
environment conducive to better self management.  
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Strengthening of Public Private Partnerships (PPP’s) e.g. partnerships with private 
pharmaceutical companies, medical aid companies, and non-government 
organisations should be encouraged. PPP’s can be benchmarked to offer expertise 
in how to improve the management of facilities, communication strategies to improve 
compliance amongst patients and motivating healthcare professionals to improve 
adherence to clinical guidelines. An example of this would be the Discovery Health 
Vitality programme which is a preventative programme for diseases of lifestyle. 
These PPP’s could also prove vital in conducting further research that identifies 
barriers that need to be overcome in order to achieve good glycaemic control.   
 
The HbA1c test is valuable and greater awareness of this should be created. This test 
can be used as a monitoring tool, as a tool for predicting diabetes complications and 
to a much lesser degree, a diagnostic tool.110 Healthcare professionals should be 
encouraged to utilise this blood test according to recommendations in national 
guidelines.  
 
However it is important that the research gaps identified be adequately addressed. 
Intervention studies aimed at motivating patients to self monitor as well as aim for 
good glycaemic control are of vital importance. Further studies should also focus on 
knowledge, attitude and practices of healthcare professionals in terms of diabetes 
management.  
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APPENDIX C:  
Methods utilised by different laboratories for blood testing 
Two of the CHCs utilized the same NHLS laboratory for all blood testing whereas the 
third CHC used a different NHLS laboratory. (Table 16) 
 
Table 16: Laboratories used for blood testing by each CHC  
 Lenasia South CHC Chiawelo CHC Discovery’s CHC 
HbA1c CHBH* NHLS  CHBH* NHLS  Johannesburg Hospital 
NHLS  
Lipids CHBH* NHLS  CHBH* NHLS  Krugersdorp NHLS  
*
Chris Hani Baragwanath Hospital (CHBH) 
Comparing the methods used for measurement between the various laboratories for 
the 3 tests, the following were noted:-  
 
HbA1c 
Both the Johannesburg Hospital and the CHBH laboratories utilize the Tin1-quant 
Hemoglobin A1c II machine to measure HbA1c based on turbidimetric inhibition for 
haemolysed whole blood. The method had been standardized against the approved 
International Federation of Clinical Chemistry (IFCC) reference method for the 
measurement of HbA1c in human blood.  
 
Lipids 
Cholesterol and triglycerides are all analysed at both the laboratories using the 
ADVIA Chemistry Systems and the Bayer Clinical Method for ADVIA 1200.  
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APPENDIX D: 
 
PATIENT QUESTIONNAIRE 
 
Interviewer I.D.:                                                                                        Study number: 
 
 
Clinic name: ----------------- 
Date of Interview:  
 
1. Socio Demography: 
 
1.1 Sex:    M 
            
1.2 Date of Birth:                                     
 
 
1.2.1 Verified with I.D book/passport/clinic card?    
 
1.3 Ethnicity:    
 
      White               Black                        Indian                      Coloured                    Other     
  
 
 
1.4 How much schooling have you completed? 
 
                                   None                                                  Less than Primary school  
 
             Primary school completed                                                   Some high school                           
                                                
                 High school completed                                                     Tertiary education 
 
 
 
 
1.5 Which of the following best describes your work status over the past 1 year? 
 
           Unemployed (but able to work)                             Unemployed (unable to work)                  
 
                                Retired/pensioner                                                        Homemaker 
 
                                      Self employed                                                             Student 
 
                        Government employee                               Non government employee 
 
                      Voluntary work (unpaid)               
 
 
                Other: Please specify------------------------------------------------------------------------------------ 
 
 
 
 
 
 
YY MM DD 
YY MM DD 
  
Y N 
     
  
  
 
  
 
  
  
 
  
  
 
M F 
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1.6 Which of the following do you have in your household at the present time? 
 
 
Electricity 
 
Yes=1 
 
No=0 
 
 
 
Television 
 
Yes=1 
 
No=0 
 
 
 
Radio 
 
Yes=1 
 
No=0 
 
 
 
Motor vehicle 
 
Yes=1 
 
No=0 
 
 
 
Fridge 
 
Yes=1 
 
No=0 
 
 
 
Washing machine 
 
Yes=1 
 
No=0 
 
 
 
Telephone 
 
Yes=1 
 
No=0 
 
 
 
Video machine 
 
Yes=1 
 
No=0 
 
 
 
Microwave 
 
Yes=1 
 
No=0 
 
 
 
2. General Diabetes Information 
 
2.1 When were you diagnosed with diabetes?  
 
2.2 Where was the diagnosis made? ------------------------------------------------------ 
 
2.3 How long have you been attending this CHC? ------------------------------------- 
 
2.4 What type of treatment are you currently on? 
 
                         Oral                           Injectable                                  Combination of both    
 
 
3. Clinic accessibility 
 
3.1 What transport do you use to get here?  
 
            Walk                                  Car                                   Taxi                                  Bus           
 
Other: Please specify------------------------------------------------------------------------------------ 
 
3.2 How long does it take you to get here? --------------- Hrs----------- min------ 
 
3.3 How much does it cost you to get here and then home again? ---------------- 
 
3.4 Is this your nearest clinic / CHC?     
      
 If not, why do they come here? ---------------------------------------------------------------------- 
 
 
4. Service satisfaction 
 
4.1 On a scale of 1-5 how friendly and helpful would you say the clinic staff are?  
1 being very unfriendly and very unhelpful and 5 being very friendly and very helpful.  
1 2 3 4 5 
 
4.2 On a scale of 1-5 how satisfied are you with the care you receive at this clinic?  
1 being very dissatisfied and 5 being very satisfied.  
YY MM DD 
1 2 3 4 5 
      
        
Y N
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5. Treatment Compliance 
 
5.1 Do you ever forget to take your medication? 
 
       Yes                           No                           Unsure      
 
5.1.1 If yes, how often does this happen?  
      
            Every day               At least once a week                   2-3 times a week 
 
           >3 times a week                   A few times a month                 Very rarely 
 
5.1.2 Have you taken your medication today?  
 
 
5.2 Have you ever been hospitalised for diabetes problems? e.g.  For high or low glucose levels.          
 
Specify? ---------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------ 
 
6. Perception of Diabetes Education 
 
6.1 Have you ever received education from this clinic on how to care for yourself    
      with regards to diabetes?        
 
6.2  Do healthcare staff inform of you of your glucose level after you are tested at this clinic?                  
 
 
What is your reading today? ----------------------------------------------------------------- 
 
6.3  Has your nurse or doctor at this clinic ever advised you to take special care of  your feet?   
 
 
6.4  Has your nurse or doctor at this clinic ever told you to follow an exercise program?     
 
 
6.5 Has your nurse or doctor at this clinic ever asked you to follow a special diet?  
 
 
                    
7. RISK FACTOR ANALYSIS 
 
7.1 Alcohol Consumption 
Have you consumed alcohol within the past 1 year?   
 
If yes, how often do you drink? 
        
  Daily                         5-6 times a week                        1-4 times a week 
          
         1-3 times a month                                                       Less than once a month 
 
When you do drink, how many standard drinks do you have at one go? i.e. on one day?--------
----------------------------------------------------------------------------------- 
 
7.2 Diet 
 
In a typical week, how many days do you eat fruit? ----------------------------------- 
 
      
   
      
Y N
Y N
Y N
Y N
Y N
Y N
Y N
      
  
Y N
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In a typical week how many days do you eat vegetables? --------------------------- 
 
7.3 Raised BP 
 
Are you a known Hypertensive?     
 
Are you currently receiving treatment for hypertension?  
 
When last was your BP checked? ---------------------------------------------------------- 
 
During the past 1 year have you ever been told that your BP is high?               
 
During the past 1 year have you been to a traditional healer or alternate healer who has said 
that your BP is high?      
 
Are you on any herbal medication, traditional medicines or homeopathic treatment for high 
BP?                                  
 
 
7.4 Physical Activity 
 
1. During the last 7 days, on how many days did you do vigorous physical activities 
like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ day/s per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one of 
those days? 
 
_____ hour/s per day _____ minute/s per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate activities refer to 
activities that take moderate physical effort and make you breathe somewhat harder than normal.  
Think only about those physical activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not 
include walking. 
 
_____ day/s per week 
 
   No moderate physical activities  Skip to question 5 
 
 
4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 
_____ hour/s per day        _____ minute/s per day 
 
  Don’t know/Not sure  
 
Y N
Y N
Y N
Y N
NY
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Think about the time you spent walking in the last 7 days.  This includes at work and at home, 
walking to travel from place to place, and any other walking that you might do solely for recreation, 
sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time?   
 
_____ day/s per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hour/s per day        _____ minute/s per day  
 
  Don’t know/Not sure  
 
 
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  Include 
time spent at work, at home, while doing course work and during leisure time.  This may include time 
spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hour/s per day _____ minute/s per day  
 
  Don’t know/Not sure  
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PATIENT MEASUREMENTS 
 
 
1. Random blood  
glucose (Mmol)          
 
 
                                                     
2. Height (cm)                
     
 
 
3. Weight (kg)                        
 
 
              
 
4. Waist circumference  
     (cm)               
                            
 
5. Blood Pressure (mm/hg) ----------------/---------------------     
 
 
7. Pulse (beats/min) 
 
 
8. Urine Analysis 
 
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------- 
 
9. Bloods taken for: 
 Y N 
HBA1C   
Creatinine   
Lipids ( total cholesterol + lipid profiles)   
Has the patient been fasting when these samples were taken?      
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APPENDIX E: 
HEALTHCARE PROFESSIONAL QUESTIONNAIRE 
 
Interviewer I.D.                                                    Participant study number 
 
 
Date of Interview:  
 
 
1.1 Do you have a diploma or higher training in chronic diseases or Diabetes      
      specifically?  
 
 If yes, specify what and from where? -------------------------------------------------------------------------------------
-------------------------------------------------------------------------------- 
 
1.2 Where do you believe that diabetes treatment at primary health care (PHC) level is most 
effectively dealt with?  
 
A) in a specific dedicated Diabetes Clinic in PHC 
 
B) in a generalised Primary Health care setting 
 
1.3 On average how many patients do you see in a diabetes clinic in a day? -- 
 
1.4 How much time do you believe is sufficient on average to ensure each patient is managed 
adequately? ------------------------------------------------------------ 
 
Comments-------------------------------------------------------------------------------------------------- 
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------ 
1.5 List some of the challenges you face whilst working in the chronic disease clinics, 
especially diabetic patient care.  
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------- 
 
2 Guideline Adherences:  
 
2.1 Are you aware that National guidelines for diabetes care at the primary level exist?           
 
 
 
2.2 Do you follow strictly the guidelines issued by the Department of Health for Diabetes 
Treatment?                
 
 
2.3 Do you have a copy of the diabetes guidelines readily available?     
 
 
 
 
 
 
 
YY MM DD 
  
Y N
  
 
Y N
Y N
Y N
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2.4 According to the guidelines: 
 
2.4.1 What random glucose level do you use to treat diabetes together with symptoms of 
diabetes? ------------------------------------------------------------- 
 
2.4.1.2 What fasting glucose level do you use to treat diabetes together with symptoms of 
diabetes? ------------------------------------------------------------- 
 
2.4.2 Can glucose in the urine (glucosuria) be used as a diagnostic tool for diabetes?  
 
 
2.4.3 What is the preferred treatment of choice for obese or overweight patients with 
diabetes? 
 
Glibenclamide                         Gliclazide                           Metformin 
 
2.4.4 How often should urinanalysis be done at clinics? ------------------------- 
 
2.4.5 What are the values used to diagnose an impaired glucose tolerance test?  
 ------------------------------------------------------------------------------------------------------- 
 
2.4.6 What is the cut off value for HBA1C? ---------------------------------------- 
 
2.4.7 How often should the HBA1C be done? ------------------------------------- 
 
 
3 Skills perception 
 
Are you comfortable performing the following tests? 
 
 Y/N 
1. Visual acuity  
2. Fundoscopy  
3. Urine dipstix  
4. Complete foot exam  
5. Neurological exam for nerve damage  
 
 
 
 
 
Y N
      
1 | P a g e  
 
APPENDIX F: 
HEALTH FACILITY MANAGER INTERVIEW 
 
1. Does this clinic have set days for seeing patients with chronic diseases?     
If Yes, Please specify the days-------------------------------------------------------------- 
2. Does this clinic have set days dedicated for Diabetic patients only?         
If yes, please specify the days--------------------------------------------------------------- 
3. Does your clinic run on an appointment system or are patients expected to arrive all at once? -------
----------------------------------------------------------------------------------------- 
4. How long has it been now that you are in the position of Clinic manager? ------------ 
 
 
5. STAFF COMPLEMENT 
 
Total NCD Diabetes 
If unavailable at this clinic, 
where do patients get 
referred to see them 
Professional nurses     
Staff Nurses     
Nursing Assistants     
Social Workers     
Dieticians     
Doctors     
Health Promoters     
Podiatrist     
Nurses with special Diabetes 
training 
    
 
 
 
 
 
7. Which hospital do you refer to complicated cases to?  
---------------------------------------------------------------------------------------------------------------- 
How far is it? (Distance)-------------------------------------------------------------------------------- 
 
6. PATIENT DATA 2008 
 
Mar Apr May June July Aug Total 
Total number of patients seen at clinic 
       
Total number of Patients seen in the Chronic 
Disease clinic 
       
Total number of new diabetics 
 
       
Total number of diabetic follow ups 
 
       
Number of patients referred to higher level of 
care 
       
Y N
Y N
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8. Are course readily available for healthcare staff if higher learning in diabetes is 
required? Specify ---------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------- 
9. Does the clinic have a system to detect defaulting diabetic patients?   
      If yes, please explain 
--------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------- 
10. Does this clinic have a system for following up defaulting patients?      N 
           If yes, please explain 
----------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------ 
11. What systems do you have in place to ensure good quality of care of Diabetic 
patients? 
--------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------- 
12. Are copies of the following available at the clinic and how many? 
 
 Y/N (n) 
National guidelines on treatment of Diabetes   
Management protocols on Type II diabetes at primary health 
care level 
  
Patient educational material related to diabetes    
 
 
13. Is there a pharmacy on site at this clinic?  
 
14. Has there ever been in interruption in the availability of medication (insulin) in the past 
6/12?    
 
 
If yes, specify when -------------------------------------------------------------------------------------  
Specify why? ---------------------------------------------------------------------------------------------- 
 
Y N
Y N
Y N
Y N
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15. Has there ever been an interruption in the availability of insulin syringes or pens?     
If yes, specify when. ----------------------------------------------------------------------------------  
 
Y N
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APPENDIX G: 
RECORD REVIEW DATA COLLECTION SHEET 
 
 Date of diabetes diagnosis/ date of start of attendance at the clinic?  
 
 
How many clinic visits for diabetes has occurred in the last 6 months? ------------------- 
 
Indicate recorded values for the following at all clinic visits during the past 6 months? 
 
 
 Dates             
                                               Laboratory  measurements 
Random Glucose 
level 
Mmol/
l  
           
HBA1C %             
T Chol Mmol/l  
           
Creatinine              
Fasting Glucose Mmol/l  
           
                                                    Non Laboratory Measurements 
Weight kg             
Height m             
BMI Kg/m2             
BP Mm/hg  
           
Health promotion 
done   
           
Dietician referral?              
Date seen by 
dietician   
           
Alcohol history 
recorded   
           
Advised on 
reducing intake?    
           
Advised to stop 
smoking.    
           
 
 
 
HBA1C last recorded result ever? ------------------------------------------------------------------- 
 
 
Number of HBA1C recorded on NHLS system for same record reviewed? -------------- 
 
 
 
 
 
 
 
 
YY MM DD 
2 | P a g e  
 
 
 
Does the patient have the following co-morbid conditions noted in the patient records? 
 
 
Condition Y/N Diagnosed >6/12 ago 
Diagnosed 
<6/12 ago 
Additional 
comments 
Hypertension     
Hypercholesterolemia     
Obesity     
 
 
 
Is there a prescription in the patient records for any of the following? 
 
 Y/N SPECIFY 
Diabetes    
Hypertension   
Lipid lowering   
Other chronic disease:   
 
 
 
Were the following examinations ever recorded in the notes? 
 
EXAM Y/N LAST RECORDED DATE 
CVS exam   
ECG   
Visual acuity   
Fundoscopy   
Foot exam by nurse   
Examination by Podiatrist   
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APPENDIX H: 
EQUIPMENT VERIFICATION 
 
 
EQUIPMENT (n) NUMBER WORKING If applicable indicate if manual or electronic 
    
1.Weighting scales 
 
   
2.Urine Glucose sticks 
 
   
3.Blood Glucometer 
 
   
4.Sphygmomanometers 
 
   
5.Stethoscopes 
 
   
6.ECG Machines 
 
   
7.Snellens Charts 
 
   
8.Fundoscopes 
 
   
9.Tape Measure 
 
   
10.Height Scale 
 
   
 
 
 
Measurements done for verification 
 1 2 3 4 5 6 7 8 9 
BP machines 
         
Weighting 
scales 
         
Glucometers 
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PARTICIPANT INFORMATION SHEET FOR PATIENT INTERVIEWS: 
 
FACTORS INFLUENCING GLYCAEMIC CONROL IN DIABETICS AT THREE 
COMMUNITY HEALTH CENTRES IN JOHANNESBURG 
 
Good day.  My name is Dr Geraldine Timothy and I am a Registrar at the WITS School of Public 
Health.  You are being invited to participate in a research study to determine factors that influence 
glycaemic control in the Johannesburg Metro District, Gauteng Province.  This form is to help you 
decide whether you wish to participate in the study or not.   
 
 
What is the Purpose of the Study? 
The research project, to be conducted from January 2009 will involve interviews with patients and 
doctors to determine what influences the control of glucose levels in the blood. I am hoping to find out 
from service providers what factors we can target to improve the way you as a patient with diabetes is 
managed.  
 
 
Why have you been chosen? 
You have been chosen to participate in this study because we are interested in determining how well 
patient’s blood glucose levels are controlled.  I would like to conduct an interview with you requiring 
about 10-15 minutes of your time, answering various questions about yourself and diabetes. We also 
would like your permission to do a blood test to determine how well controlled your blood glucose 
level is. Lastly we wish to do a few measurements for you, i.e. height, weight, and waist.  
 
 
Participation is voluntary: I would like to stress that this is voluntary, and you may choose not to 
participate or to discontinue participation at any time. 
 
 
Risks: There are no foreseeable risks to your participating.  Very minor discomfort might be 
experienced whilst taking your blood for testing. Drawing blood is part of your routine  
medical examination as a patient with diabetes. This will be exactly the same amount of  
discomfort you are already accustomed to as a diabetic patient. 
 
 
Benefits: The benefits of taking part in this study include having a role in improving the control of 
diabetes in the district. 
 
 
Confidentiality 
Your identity will not be revealed and your confidentiality will be protected in any reviews and reports 
of this study which may be published.   
 
 
Contact details 
If you have any questions or concerns or would like more information about this study please contact: 
Geraldine Timothy, Principal Investigator on the study, at 076 646 2369 or e-mail 
geraldine.timothy@wits.ac.za 
 
If you are unhappy with the way this research is conducted, you are welcome to contact the Chair of 
the Wits Human Ethics Committee Prof P Cleaton Jones through his secretary Ms Anisa Keshav on 
011-717-1234 
 
Thank you for taking time to read this sheet. 
Dr Geraldine Timothy 
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PARTICIPANT INFORMATION SHEET FOR HEALTH CARE PROFESSIONAL 
INTERVIEWS 
   
 FACTORS INFLUENCING GLYCAEMIC CONROL IN DIABETICS AT THREE 
COMMUNITY HEALTH CENTRES IN JOHANNESBURG 
 
Good day.  My name is Dr Geraldine Timothy and I am a Registrar at the WITS School of Public 
Health.  You are being invited to participate in a research study to determine factors that influence 
glycaemic control in the Johannesburg Metro District, Gauteng Province.  This form is to help you 
decide whether you wish to participate in the study or not.   
 
 
What is the Purpose of the Study? 
The research project, to be conducted from January 2009 will involve interviews with health care 
professionals working with diabetic patients at primary clinics to determine what influences the control 
of glucose in the blood. I am hoping to find out from service providers what factors we can target to 
improve the burden of disease caused by diabetes.  
 
 
Why have you been chosen? 
You have been chosen to participate in this study because we are interested in determining health 
care professional factors that influence blood glucose levels.  I would like to conduct an interview with 
you requiring about 10-15 minutes of your time, answering various questions about how you perceive 
diabetes management. I would like to stress that this is voluntary, and you may choose not to 
participate or to discontinue participation at any time. 
 
 
Confidentiality 
Your identity will not be revealed and your confidentiality will be protected in any reviews and reports 
of this study which may be published.   
 
 
Are there any disadvantages or benefits to taking part? 
There are no foreseeable risks to your participating.  The benefits of taking part in this study include 
having a role in improving the control of diabetes in the district. 
The Gauteng Department of Health has approved this project. Feedback of our findings will be offered 
to them. You can be assured of your anonymity as well as your Facilities anonymity in the feedback 
thereby NOT exposing any healthcare professional to any form of victimisation or repercussions from 
the study.  
 
Contact details 
If you have any questions or concerns or would like more information about this study please contact: 
Geraldine Timothy, Principal Investigator on the study, at 076 646 2369 or e-mail 
geraldine.timothy@wits.ac.za 
 
If you are unhappy with the way this research is conducted, you are welcome to contact the Chair of 
the Wits Human Ethics Committee Prof P Cleaton Jones through his secretary Ms Anisa Keshav on 
011-717-1234 
 
Thank you for taking time to read this sheet. 
Dr Geraldine Timothy 
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Informed Consent 
 
Adult Patient Participant 
 
FACTORS INFLUENCING GLYCAEMIC CONROL IN THREE COMMUNITY HEALTH 
CENTRES IN THE CITY OF JOHANNESBURG 
 
The research project- Factors influencing glycaemic control in three community 
health centres in the City of Johannesburg: 
 
1. Has been explained to me. I understand that it involves a face to face 
questionnaire administered by a research assistant. I do not mind giving 
information about myself, my general health. 
 
2. I understand that a blood test is required. I do not mind having this test done 
on me.  
 
3. I understand that while the study may not have any direct benefits for me, it 
will help researchers to understand how diabetes management can be 
improved in the Gauteng province. 
 
4. I understand that my name, address, and other personnel information will not 
be recorded on the questionnaire forms and thus ensuring my confidentiality. 
 
5. I understand that I do not have to take part in this project. If I choose not to 
take part or decide not to answer a question, this will not affect the way, in 
which I will be treated at the health facility. Similarly, if I choose to withdraw 
from this project at any stage, this will not prejudice me in anyway in the 
future. 
 
 
 
Name of Patient participant:                               Name of Research Assistant: 
_________________________ __________________________ 
 
 
Signature of Patient-participant                          Signature of Research assistant 
 
_________________________ __________________________ 
 
 
 
 
 
 
Date 
 d  d  m m 2  0      
   Study No      
ff   ff   d  d  p  p  
   GT number    
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Informed Consent 
 
Health Care Professionals 
 
FACTORS INFLUENCING GLYCAEMIC CONROL IN THREE COMMUNITY HEALTH 
CENTRES IN THE CITY OF JOHANNESBURG 
 
 
The research project- Factors influencing glycaemic control in three community 
health centres in the City of Johannesburg: 
 
1. Has been explained to me. I understand that it involves a face to face 
questionnaire administered by a research assistant. I do not mind giving 
information about my clinical practices. 
 
2. I understand that while the study may not have any direct benefits for me, it 
will help researchers to understand how diabetes management can be 
improved in the Gauteng province. 
 
3. I understand that my name, address, and other personnel information will not 
be recorded on the questionnaire forms and thus ensuring my confidentiality. 
 
4. I understand that I do not have to take part in this project. If I choose not to 
take part or decide not to answer a question, this will not affect the way, in 
which I will be treated at the health facility. Similarly, if I choose to withdraw 
from this project at any stage, this will not prejudice me in anyway in the 
future. 
 
 
 
Name of participant:                                           Name of Research Assistant: 
 
_________________________ __________________________ 
 
 
Signature of participant                                       Signature of Research assistant 
 
_________________________ __________________________ 
 
 
 
Date 
 d  d  m  m  2  0      
   Study No      
ff   ff   d  d  p  p  
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INFORMATION SHEET FOR FACILITY MANAGERS 
   
FACTORS INFLUENCING GLYCAEMIC CONROL IN THREE COMMUNITY HEALTH 
CENTRES IN THE CITY OF JOHANNESBURG 
 
Dear Facility manager.  My name is Dr Geraldine Timothy and I am a Registrar at the WITS  
School of Public Health.  You and your facility are being invited to participate in a research  
study to determine factors that influence glycaemic control in the Johannesburg Metro  
District, Gauteng Province.  This form is to help you decide whether you wish to participate  
in the study or not.   
 
What is the Purpose of the Study? 
The research project, to be conducted from January 2009 will be conducted at three  
Community Health Centres already randomly selected in the Johannesburg Metro District.  
The study will consist of a few components.  
It will involve interviews with diabetic patients attending at the CHC’s, interviews with health  
care professionals at the CHC’s as well as an interview with you the facility manager.  
Records of the same patients to be interviewed will also be reviewed.  
Interviews will be conducted by myself as well as a research assistant. Confidentiality of all  
participants will be maintained.  
We are hoping to find out from these facilities what factors we can target to improve the  
burden of disease caused by diabetes.  
 
Why have you been chosen? 
Your facility was randomly chosen for this study from all the CHC’s in the JHB metro district.  
I would like to stress that this is voluntary, and you may choose not to participate or to discontinue 
participation at any time. 
 
Confidentiality 
Your identity as well as your facilities identity will not be revealed and your confidentiality will  
be protected in any reviews and reports of this study which may be published.   
 
Are there any disadvantages or benefits to taking part? 
There are no foreseeable risks to your participating.  The benefits of taking part in this study include 
having a role in improving the control of diabetes in the district. Feedback will be offered to your 
facility and reflection on the findings will obviously benefit your institute.  
The Gauteng Department of Health has approved this project. Feedback of our findings will be offered 
to them. You can be assured that there will be no repercussions from the study and no form of 
victimisation will occur. Names of healthcare professionals will be kept confidential in the report. 
Please also note that researchers and research assistants will be well trained in their responsibilities 
and professionalism will be guaranteed at all times. 
 
Contact details 
If you have any questions or concerns or would like more information about this study please contact: 
Geraldine Timothy, Principal Investigator on the study, at 076 646 2369 or e-mail 
geraldine.timothy@wits.ac.za 
 
If you are unhappy with the way this research is conducted, you are welcome to contact the Chair of 
the Wits Human Ethics Committee Prof P Cleaton Jones through his secretary Ms Anisa Keshav on 
011-717-1234 
 
Thank you for taking time to read this sheet. 
 
Dr Geraldine Timothy 
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INFORMED CONSENT: FACILITY MANAGER 
 
FACTORS INFLUENCING GLYCAEMIC CONROL IN THREE COMMUNITY HEALTH 
CENTRES IN THE CITY OF JOHANNESBURG 
 
 
The research project- Factors influencing glycaemic control in three community 
health centres in the City of Johannesburg: 
 
1. Has been explained to me. I understand that it involves a face to face 
questionnaire administered by the principal investigator. I do not mind giving 
information about my clinical practices. 
 
2. I understand that while the study may not have any direct benefits for me, it 
will help researchers to understand how diabetes management can be 
improved in the Gauteng province. 
 
3. I understand that my name, address, and other personnel information will not 
be recorded on the questionnaire forms and thus ensuring my confidentiality. 
 
4. I understand that I do not have to take part in this project. If I choose not to 
take part or decide not to answer a question, this will not affect the way, in 
which I will be treated at the health facility. Similarly, if I choose to withdraw 
from this project at any stage, this will not prejudice me in any way in the 
future. 
 
 
 
Name of participant:                                           Name of Researcher: 
 
_________________________ __________________________ 
 
 
Signature of participant                                       Signature of Researcher 
 
_________________________ __________________________ 
 
 
 
Date 
 d  d  m  m  2  0      
   Study No      
ff   ff   d  d  p  p  
 
 
 
 
 
 
   Facility Name  
                    
